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CHAPTER I 
INTRODUCTION 
Objective 
 Atherosclerosis and its clinical complications are a major cause of mortality in 
developed countries, yet much remains to be learned concerning factors influencing 
disease initiation and progression.  The hallmark of the disease is the presence of 
macrophages that continually engulf lipid and develop into macrophage foam cells.  
During early stages of atherosclerosis the lipid that is engulfed is primarily stored as 
cytoplasmic droplets.  However, as the lesion progresses, the lipid storage shifts to the 
lysosome.  The lysosomal accumulation of lipid led de Duve and colleagues to suggest 
atherosclerosis was a lysosomal storage disorder (Peters et al., 1972; de Duve, 1974; 
Peters and de Duve, 1974).  To date the exact mechanism of this lysosomal accumulation 
has not been identified.  Furthermore, it has been demonstrated that there is an excess of 
free cholesterol (FC) in the advanced lesion (Li et al., 2005), which is inconsistent with 
cytoplasmic storage.  Moreover, the excess FC could potentially activate macrophage cell 
death (Zhou et al., 2005).  Studies in our lab and others, using macrophages in tissue 
culture, indicated that after a brief period of lipid uptake the lysosomes of the 
macrophages fail to hydrolyze the cholesterol ester (CE) on modified lipid particles 
(Jerome et al., 1998; Yancey and Jerome, 1998; Dhaliwal and Steinbrecher, 2000; 
Yancey and Jerome, 2001).  Therefore, we hypothesized that lysosomal lipid 
accumulation altered the lysosomal environment such that the lysosomes were no longer 
able to hydrolyze lipid particles or degrade proteins causing them to be sequestered in the 
lysosomes.  The research presented in this dissertation focuses on understanding the 
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mechanisms for this lysosomal lipid sequestration by exploring the effect of free 
cholesterol on lysosomal function and activity of the vacuolar ATPase.   
 
Pathogenesis of atherosclerosis  
 Cardiovascular disease is the leading cause of death in the western world, 
accounting for more deaths than the next two causes combined (AHA, 2004).  
Atherosclerosis, the leading single cause of cardiovascular disease, is a very insidious 
disease starting during the teenage years, but not exhibiting clinical complications until 
the fourth or fifth decade of life (Shoen and Coltran, 1999).  This indicates that there may 
be a time dependent component to atherosclerosis; however, atherosclerosis lesion 
development is more closely related to circulating lipoprotein levels.  This has lead 
Williams and Tabas to develop the “response to retention” hypothesis, which states that 
lipoproteins, mainly low density lipoproteins (LDL), become trapped in the arterial 
intimal space and become modified (Williams and Tabas, 1995; Williams and Tabas, 
2005).  It is this retention-induced modification that leads to the recruitment of 
macrophages and uptake of modified lipid particles, which are key components of the 
development of macrophage foam cells. Foam cells are macrophages which have entered 
the artery wall and engulfed large quantities of lipid.  The accumulation of lipid leads to 
large lipid swollen vacuoles, which give them a foamy appearance.  The presence of 
macrophage foam cells is the hallmark of an atherosclerotic lesion.  The further 
recruitment of macrophages and their development into additional foam cells eventually 
lead to the formation of clinically significant lesions.  Moreover, the retention hypothesis 
has been refined to include the role that inflammation plays in the development of 
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clinically significant lesions (Ross, 1999).  The inflammatory component is due not only 
to the recruitment of macrophages, but also the recruitment of other immune cells, such 
as T-cells and the production of inflammatory cytokines by cells within the lesion 
(reviewed by (Stoll and Bendszus, 2006)).  As the lesion advances, smooth muscle cells 
are recruited from the arterial media into the developing lesion.  Upon recruitment, the 
smooth muscle cells begin to secrete matrix proteins which can help stabilize the lesion 
(Jerome and Lewis, 1985).  Clinically significant lesions often have a high lipid to matrix 
ratio and a thin fibrous cap.  These lesions are prone to rupture, resulting in hemorrhage 
and thrombosis leading to myocardial infarction or stroke.   
 One basic mechanism for the development of the atherosclerotic lesion is the 
entrapment of LDL within the arterial intima leading to the modification of the LDL 
particles (Brown and Goldstein, 1976; Brown et al., 1979).  Modification of LDL is 
important because it allows macrophages to take up these particles through unregulated 
scavenger receptor pathways and not through the highly regulated LDL receptor pathway.  
Kruth et al. have shown that there is an accumulation of FC in the subendothelial space 
prior to morphological changes in the vessel (Kruth, 1985). In addition to the 
accumulation of cholesterol, atherosclerotic lesions develop at sites in the artery that have 
turbulent flow characteristics, such as branch points and areas of high stress (Jerome and 
Lewis, 1984; Shoen and Coltran, 1999).  It is believed that this turbulent flow is partially 
responsible for the initiation of atherosclerosis because it induces changes to the 
endothelial layer, which may precipitate the extravasation of the LDL and monocytes into 
the arterial intima (Jerome and Lewis, 1984).  
 3
As atherosclerotic lesions progress to more advanced states, other sources of 
lipids besides LDL become available to macrophages and there is further recruitment of 
monocytes. Some of the lipid particles that accumulate in the subendothelial space are 
aggregates of LDL (agg-LDL) (Hoff et al., 1992).  Interestingly, these aggregates can 
interact with the endothelial layer, aiding in their retention within the sub endothelial 
space (Zhao et al., 2004).  In addition to agg-LDL, there are both CE-containing particles 
that differ from native lipoproteins and FC-containing particles that have a multilaminar 
structure present within the atherosclerotic lesion (Chao et al., 1990).  Small FC crystals 
associated with calcium crystals have also been identified in advanced atherosclerotic 
lesions (Hirsch et al., 1993).  The various lipids provide several sources of extracellular 
lipid for the macrophages present in the lesion to engulf.  Thus, there is an increase in 
both the number of macrophages and the amount of lipid stored within each foam cell 
(Jerome and Lewis, 1985; Jerome and Lewis, 1987).  
When the lesion reaches an advanced state, a necrotic core can begin to form.  
Part of the developing necrotic core is formed from the death of some of the lipid laden 
foam cells.  As these macrophages die the accumulated lipid is no longer maintained 
within the cell (Bjorkerud and Bjorkerud, 1996)(reviewed in (Littlewood and Bennett, 
2003)) and results in a release of the contents into the extracellular space (Yao and Tabas, 
2000; Geng et al., 2003).  The released lipid becomes another source of lipid for 
surrounding macrophages to engulf.  While the exact mechanism of cell death is not 
known, either of these processes will provide large quantities of acellular lipid to adjacent 
macrophages (Kellner-Weibel et al., 1998; Feng et al., 2003).  In the case of cell death 
from necrosis, the various cellular enzymes would be released from the cell (Rosenfeld et 
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al., 1991).  The release of the enzymes can generate an environment that would be 
conducive to lipid modification and uptake by macrophages (Rosenfeld et al., 1991).  
This is in contrast to death by apoptosis because the enzymes would then be packaged in 
apoptotic bodies.  The more the necrotic core grows the more unstable the lesion 
becomes and the more potential there is for a clinical event to occur (Shoen and Coltran, 
1999). Furthermore, the lipid produced from cell death is not packaged as a normal 
lipoprotein particle.  The packaging of the lipid could potentially inhibit processing of the 
particle.  The inhibition of processing could therefore quickly override the degradation 
and transport systems of the lysosomes when compared with single particle uptake 
occurring through receptor mediated endocytosis.  The inhibition of processing is 
potentially the mechanism behind the observation that agg-LDL particles accumulate 
undegraded in the lysosome (Haberland et al., 2001). 
 
Modifications of LDL   
During initial lesion development, LDL modification plays a major role in lesion 
development.  Several modifications of the LDL can occur that could lead to high cellular 
lipid accumulation.  One of the major modifications, which occurs in the lesion, is 
oxidation of the LDL particle.  Pathways in which oxidation can occur include, but are 
not limited to, attack of lipids by lipoxygenases and superoxide (Rosenfeld et al., 1991; 
Egan et al., 2005).   Modification of the lipoproteins through the action of lipoxygenase 
or superoxide results in oxidation of the particles, which places negatively charged 
residues on the surface of the LDL particles.  These negatively charged moieties allow 
for binding of the particles to scavenger receptors facilitating their unregulated uptake. 
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Oxidation of LDL is known to occur in the vessel wall and represents a physiologic 
modification that can be studied using tissue culture (Rosenfeld et al., 1991).  However, 
there are large variations in both the methods and levels of oxidation of LDL particles 
produced in vitro trying to mimic that found in the lesion.  These variations in both the 
type and level of oxidation often make comparing studies difficult (Boullier et al., 2006).  
A second physiological modification of LDL is aggregation, which can occur through 
several pathways.  The best characterized pathways are through the actions of lipases on 
the LDL and/or the clumping of oxidized particles (Hoff and O'Neil, 1991; Boyanovsky 
et al., 2005).  Aggregated particles can be taken into macrophages through a variety of 
mechanisms including scavenger receptor-mediated endocytosis and macropinocytosis.  
Recently, the laboratory of Kruth showed that stimulation of macrophages with M-CSF 
leads macrophages in culture to greatly increase cell surface activity and stimulation of 
lipid accumulation from unmodified LDL (Zhao et al., 2006).  Thus, if aggregates are 
present in the lesion, even greater cellular lipid accumulation may occur.    
A well characterized, but non-physiologic, modification of LDL that increases its 
uptake is acetylation (Basu et al., 1976; Brown et al., 1979; Kunjathoor et al., 2002), 
which places a highly negative charge on the lysine residues of apo B, the major 
apolipoprotein of the LDL (Basu et al., 1976).  This modification led to the discovery of 
the scavenger receptor pathway (Brown et al., 1979).  Uptake of acetylated-LDL (ac-
LDL)by scavenger receptors results in the unregulated uptake of lipid into the 
macrophage.  Ac-LDL has been utilized extensively in the study of cellular cholesterol 
metabolism and transport, but has been shown to be different from the other physiologic 
modifications of LDL (Brown et al., 1979; Jerome et al., 1998; Yancey and Jerome, 
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1998; Yancey and Jerome, 2001; Yancey et al., 2002).  Acetylation of LDL leads to 
altered processing of the LDL compared with that of oxidized LDL (ox-LDL) (Yancey 
and Jerome, 2001).  However, the altered processing is not due to a difference in uptake 
and delivery to the lysosome as both oxidized and acetylated labeled particles are 
delivered to the same lysosomes in a tissue culture model (Yancey et al., 2002).  
Additional differences between ac-LDL and physiological modifications of LDL will be 
discussed further in the chapter on macrophage cholesterol metabolism. 
 
Macrophage foam cell development  
In order for macrophages to become foam cells, circulating monocytes must first 
extravasate through the artery wall into the intima.  All of the initiating mechanisms 
behind this extravasation are not known, but there is a cytokine gradient produced from 
endothelial cells and other cells in the developing lesion (Shoen and Coltran, 1999).   
Furthermore, disruption of the endothelial cells leads to expression of cell adhesion 
molecules, such as selectins and ICAM-1, on the cells surface (Cybulsky and Gimbrone, 
1991; O'Brien et al., 1996).  Selectin expression leads to a rolling of the monocytes along 
the surface of the vessel wall.  Once slowed by selectin binding, the monocytes express 
LFA-1, the binding partner of ICAM-1, resulting in a tighter adhesion and a tethering of 
the monocyte to the endothelial layer.  The tethering of the monocyte allows the 
monocyte to transmigrate between adjacent endothelial cells and enter the arterial intima 
(Cotran et al., 1999).   
During extravasation, the monocytes differentiate into macrophages under the 
influence of cytokines (Shoen and Coltran, 1999). Differentiation leads to a marked 
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upregulation of scavenger receptors, mainly CD36 and scavenger receptor type A (SR-A) 
(Kunjathoor et al., 2002).   Upregulation of scavenger receptors allows for the binding of 
modified LDL as discussed above.  Once bound to the scavenger receptors, the modified 
LDLs are internalized and delivered to the lysosome through the endocytic pathway, 
(covered in more detail below).  Once in the lysosome, the particles normally undergo 
degradation by several proteases and lipases, mainly cathepsin D, acid sphingomyelinase, 
and lysosomal acid lipase, which degrade apolipoprotein (apo) B, sphingomyelin, and 
CEs, respectively.  After degradation the molecules are transported out of the lysosome 
for use or storage by the cells.  However, de Duve and colleagues found an expansion of 
the lysosomal compartment in atherosclerosis (de Duve, 1974).   The expansion of the 
lysosomes led them to suggest that atherosclerosis is a lysosomal storage disorder (de 
Duve, 1974).  Our laboratory and others have also found an expansion of the lysosomal 
compartment associated with lipid accumulation (Jerome and Lewis, 1985; Jerome and 
Lewis, 1987).  In macrophages in culture the lysosomal accumulation is accompanied by 
a reduction in hydrolysis of the lipoprotein CEs as foam cells develop (Yancey and 
Jerome, 1998; Dhaliwal and Steinbrecher, 2000; Yancey and Jerome, 2001).  These data 
suggest there is a significant portion of foam cell development attributed to the lysosome.  
 
Lysosomal formation and biology 
 Lysosomes are membrane bound organelles that degrade protein and lipid 
through a variety of digestive enzymes that require an acidic pH to function.  Lysosomal 
acidity is produced and maintained by the vacuolar-type H+-ATPase (v-ATPase).  
Initially lysosomes were characterized in rat liver cells based on the presence of a single 
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enzyme, acid phosphatase (de Duve et al., 1955), but are now known to contain over 50 
acid hydrolases (Bainton, 1981).   Lysosomes are also unique cellular organelles because 
they have no defined shape, size, or cellular location.  With this fact in mind, it has been 
postulated that there are two different populations of lysosomes: 1.  primary lysosomes, 
which are vesicles containing hydrolytic enzymes that are formed by budding from the 
Golgi apparatus and the ER (Bainton, 1981; Lodish et al., 2000); 2.  secondary 
lysosomes, which result from the fusion of the primary lysosomes with endosomes, 
phagosomes or autophagosomes (Lodish et al., 2000) (Figure 1).  It has also been shown 
that clathrin coated vesicles associate with primary lysosomes possibly for the delivery of 
enzymes (Friend and Farquhar, 1967; Holtzman et al., 1967).  The role of lysosomes in 
cellular biology is multi-factorial: they eliminate damaged and unnecessary proteins 
(Goldberg and Dice, 1974), play a role in cell cycle and differentiation (Finley and Chau, 
1991), and help facilitate antigen presentation (Castellino and Germain, 1995).  Recently, 
genes of the atherosclerotic lesion have been characterized.  Of particular interest to the 
studies presented in this dissertation, the genes for v-ATPases were among the genes 
differentially regulated between normal and atherosclerotic tissue (Forcheron et al., 
2005). At a minimum, this underscores the involvement of lysosomes in atherosclerosis, 
but may also indicate that pH regulation is a factor in atherogenesis.   
As for the lysosome’s role in cholesterol regulation and atherosclerosis, it has 
been demonstrated, under normal cellular conditions, that LDL CEs are degraded in the 
lysosome.  Once degraded, the FC generated from CE hydrolysis is then transported out 
of the lysosome for use or storage by the cell.  As cellular cholesterol levels increase, 
there is a reduction in synthesis of the LDL receptor.  At the same time, LDL receptors 
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are internalized and transferred to the lysosome for degradation (Goldstein and Brown, 
1977) (Figure 1).  Additionally, the cholesterol generated from LDL hydrolysis, in 
normal cells, is transferred to the plasma membrane and ER.  The cholesterol in the ER 
results in the down regulation of 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) 
reductase, the rate limiting enzyme in cholesterol biosynthesis (Brown et al., 1980).  
Interestingly, supplementation of the lysosome enzyme lysosomal acid lipase has been 
shown to lead to a significant reduction in atherosclerotic lesion formation (Du et al., 
2004).   
 
Cellular cholesterol  
Cellular cholesterol levels  
The bulk of the cellular cholesterol is found in the plasma membrane (Lange and Ramos, 
1983; Lange et al., 1989; Meer, 1989; Warnock et al., 1993).  Endosomes, lysosomes, 
and the trans-Golgi network contain significant amounts of cholesterol, with the levels 
decreasing as the vesicles move away from the plasma membrane (Colbeau et al., 1971).  
There are very low levels of cholesterol in the mitochondria, ER, and cis-Golgi.  
Although the ER cholesterol pool is small, the majority of the plasma membrane pool of 
cholesterol circulates through the ER with a half-time of approximately 40 minutes 
(Lange et al., 1993).  This would be consistent with cholesterol efflux data suggesting 
there are at least 2 pools of cholesterol, a fast and slow effluxing pool (Yancey et al., 
1996).  The fast pool occupies the plasma membrane and the slow pool consists of 
internalized cholesterol (Yancey et al., 1996).   Additionally, after depletion of the fast 
pool, the cholesterol within this pool could be replenished after approximately 40 minutes 
(Yancey et al., 1996).  
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Figure Label Compartment Prominent Markers 
1 Early Endosome EEA-1(Simonsen et al., 1998) 
2 Recycling Endosome rab 4, cellubrevin (Gagescu et al., 2000) 
3 Late Endosome M6P R(Lodish et al., 2000), syntaxin 
4 Primary lysosome  M6P R(Lodish et al., 2000) 
5 Early Phagosome VAMP 3, Rab 5 (Scott, JMB 2003) 
6 Late Phagosome Rab 7, Rab 9 (Scott JMB 2003) 
7 (Secondary) Lysosome LAMP-1, Cathepsin D(Conner, 1998) 
 
Figure 1:  Diagram of phagosomal and lysosomal formation and biologic 
markers.  Endocytosis starts with the internalizing of a portion of membrane with a given 
set of receptors present and often involves a clathrin dependent process (1).  After a slight 
acidification, causing the receptor to release its cargo, the receptor can recycle to the cell 
surface through a recycling endosome (2).  The cargo continues down the endocytic 
pathway to the late endosome (3).  The late endosome can then fuse with a primary 
lysosome, which consists of lysosomal enzymes budding from the trans-Golgi network 
(4).  This leads to the formation of the secondary lysosome or what is traditionally termed 
the lysosome (7).  Phagocytosis, which can be mediated by receptors, is a means by 
which the cell can internalize larger particles.  This process involves the budding of the 
plasma membrane around the particle, the internalization of the membrane and particle, 
and the pinching off of the plasma membrane.  This forms an early phagosome, which 
often has similar markers to the early endosome (5).  As the phagosome matures it loses 
some of the markers and becomes more acidic, resulting in the formation of the late 
phagosome (6).  These vesicles can then fuse with the primary lysosomes resulting in a 
phagolysosome, which cannot be distinguished from the secondary lysosome (7).  
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  Cholesterol synthesis 
FC is essential for proper cell growth and membrane function.  Nearly all cells 
synthesize cholesterol, a complex process involving over 26 enzymes and several 
precursors.  The rate limiting step in the synthesis of cholesterol takes place in the ER 
and is performed by the enzyme HMG-CoA reductase (Brown et al., 1973).  Inhibition of 
this enzyme in the liver can significantly reduce systemic LDL levels and reduce overall 
levels of apo B-containing lipoproteins (Arad et al., 1990).  The regulation of sterol 
production has been further examined and is now known to involve several steps and 
proteins.  The major group of transcription factors involved in the regulation of sterol 
synthesis and uptake are the sterol regulatory element binding proteins (SREBPs), which 
activate over 30 sterol related genes (reviewed (Horton et al., 2002)).  The regulation of 
the SREBPs is controlled by three additional proteins; SREBP cleavage-activating 
protein (SCAP), Site-1 protease (S1P), and Site-2 protease (S2P) (reviewed (Horton et 
al., 2002)).  SCAP is located in the ER, binds to SREBP, and directs the movement of 
SREBP between the ER and the Golgi (Yang et al., 2002).  In conditions of high 
cholesterol SCAP binds directly to cholesterol, through a sterol sensing domain, 
(Radhakrishnan et al., 2004) and is retained in the ER through binding to INSIG-1 (Yang 
et al., 2002).  Retention of SREBP in the ER inhibits activation of SREBP and in turn 
cholesterol synthesis.  Conversely, if cholesterol is low the SCAP- SREBP complex 
moves to the Golgi where SREBP undergoes cleavage via S1P and S2P, releasing the 
transcription factor portion of the protein, which then translocates to the nucleus (Duncan 
et al., 1997; Duncan et al., 1998).  Three SREBPs (SREBP-1a, SREBP-1c, and SREBP-
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2) have been identified.  Of these, SREBP-2 regulates genes involved in sterol production 
and regulation (Horton et al., 1998). 
  
Cholesterol uptake 
Although cells can synthesize cholesterol, they can also acquire cholesterol 
through the LDL receptor pathway.  The LDL receptor is expressed on the cell surface 
where it binds to LDL (Brown and Goldstein, 1976).  It is then internalized through a 
clathrin dependent process (Goldstein et al., 1979) and enters the endocytic pathway, the 
first compartment of which is the early endosome.  As the endocytic compartments start 
to be acidified the receptor releases the LDL particle.  The receptor can then enter two 
separate pathways: 1. it can be recycled to the cell surface through a recycling endosome;  
2. if the cell senses it has sufficient cholesterol levels it will continue down the endocytic 
pathway and eventually be degraded in the lysosome.  This pathway is also very tightly 
regulated at the level of the LDL receptor (Goldstein et al., 1979).  Primary human 
monocytes in culture show maximal LDL receptor expression within 6 days (Fogelman et 
al., 1981), although the cells will subsequently downregulate the LDL receptor, unless 
they are cultured in conditions of serum starvation (Fogelman et al., 1981).  Furthermore, 
incubation of macrophages with LDL leads to a down regulation of the surface 
expression of the LDL receptor.  Treatment of cells with malondialdehyde-altered LDL, a 
modified form of LDL, leads to an even larger down regulation of LDL receptor 
expression (Fogelman et al., 1981). The downregulation of the LDL receptor is in direct 
response to the increasing cellular cholesterol.  It has also been found that up to seventy 
percent of LDL clearance occurs in the liver and the other thirty percent is therefore from 
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extrahepatic uptake (Pittman et al., 1982).  Ac-LDL uptake is at least 2 fold greater than 
normal LDL uptake in the macrophage (Brown and Goldstein, 1983).  Therefore, the role 
that the LDL receptor plays in atherosclerosis can be debated and scavenger receptor 
uptake may be more important in this system.   
 
Macrophage cholesterol uptake 
The macrophage being a scavenging cell has developed pathways to bypass the 
tightly regulated LDL receptor mediated uptake of LDL.  These pathways, while 
potentially beneficial in clearance of the offending particles, do lead to the unregulated 
uptake of cholesterol that contributes to the development of atherosclerosis.  A major 
pathway to bypass the LDL receptor’s limited uptake of cholesterol is through scavenger 
receptor uptake.  Two additional pathways that bypass the LDL receptor are 
macropinocytosis and phagocytosis.  These pathways take up particles that are in the 
surrounding extracellular space, but receptors are not required for particle uptake.  
Scavenger receptor uptake of lipid particles has been identified as a major 
pathway of lipid uptake leading to the production of macrophage foam cells (Krieger et 
al., 1993; Kunjathoor et al., 2002).  There are two major scavenger receptors that have 
been identified to play this role, CD-36 and SR-A; however, their respective role in 
different systems has been debated (Kunjathoor et al., 2002).  It is believed that SR-A 
plays a larger role in human models of foam cell development, but CD-36 may play a 
larger role in mouse models (Kunjathoor et al., 2002).  While not clearly identified, it is 
also believed that there may be receptors specific for oxidized LDL.  Some candidates for 
uptake of ox-LDL are SR-A (Krieger et al., 1993), Fc-gamma receptor II type B2 
 14
(Stanton et al., 1992), lectin-like oxidized LDL receptor-1(Yoshida et al., 1998), and CD 
68 (Ramprasad et al., 1995).   With regard to scavenger receptor uptake, there are several 
modifications of LDL which result in uptake via this pathway as discussed previously.  
The uptake of unmodified LDL, small aggregates of LDL (agg-LDL), and the 
protein free lipid droplet go through the endocytic pathway terminating at the lysosome.  
It could be argued that they go through a phagocytic process that is different than 
receptor mediated endocytosis.  However, it has been demonstrated that these particles 
induce macrophage foam cells that closely resemble those induced by ox-LDL (Griffin et 
al., 2005).  This is most likely due to these pathways merging downstream at lysosomes 
(Minor et al., 1991; Maor et al., 1995; Yancey and Jerome, 1998; Dhaliwal and 
Steinbrecher, 2000; Yancey and Jerome, 2001).  Therefore, the lysosomal sequestration 
of the lipid and the mechanisms for the lysosomal expansion may be of more importance 
in foam cell development than how the particles are endocytosed into the cell. 
 
Cholesterol Storage and Efflux 
As previously mentioned, FC is both essential and potentially toxic to cells.  However, 
while cells can synthesize and endocytose cholesterol they do not have the ability to 
degrade cholesterol.   Furthermore, only in the liver can cholesterol be excreted from the 
body in the form of bile acids.  The bile acids can then be excreted into the feces and 
excreted from the body.  For these reasons, cells have developed a specialized way for 
handling excess cholesterol, mainly cholesterol storage and efflux.  A small amount of 
excess cellular cholesterol can be stored in the plasma membrane of the cell.  However, if 
this level increases over that which can be accommodated in the membrane, there are 
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sterol sensors in the ER which activate expression and activity of aceyl-coA:cholesterol 
aceyltransferace (ACAT) (Chang et al., 1993).  Two separate forms of this enzyme have 
been characterized and functionally expressed in different models (Anderson et al., 1998; 
Cases et al., 1998; Lee et al., 2000).  These enzymes are present in the ER membrane and 
are responsible for esterifying a fatty acid to FC resulting in the formation of a CE.  In the 
case of ACAT-1, the CE generated is transported and stored in a cytoplasmic lipid 
droplet.  Increased levels of ACAT-1 are seen in monocytes that differentiate into 
macrophages (Miyazaki et al., 1998).  ACAT-2, which is specifically expressed in the 
liver and intestine, generates CEs that are incorporated into apo B containing lipoproteins 
(Lee et al., 2000).  If the cellular cholesterol level drops, cytoplasmic CE is acted on by 
either hormone sensitive lipase (Johnson et al., 2000) or, more likely, neutral cholesteryl 
ester hydrolase (NCEH) (Ghosh, 2000).  The activation of these enzymes results in the 
hydrolysis of cytoplasmic CE to FC and a fatty acid (Figure 2).  
Since cells are unable to degrade cholesterol, extrahepatic cells have developed 
specialized methods to rid themselves of excess FC; namely they have the ability to 
efflux cholesterol to extracellular acceptors. They can do this through three separate 
pathways.  The first pathway is efflux by simple aqueous diffusion.  This pathway is not 
an efficient means to efflux large amounts of cholesterol because of the relative 
insolubility of cholesterol in aqueous solutions.  However, efflux by aqueous diffusion is 
dependent on several factors including the cholesterol concentration and the size and 
composition of the acceptor molecules present (Phillips et al., 1987; Lund-Katz et al., 
1988).  A second cholesterol efflux mechanism is through scavenger receptor type-B1 
(SR-B1).  SR-B1 is a bidirectional cholesterol transporter, which has the ability to efflux  
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Figure 2:  Diagram of cellular cholesterol movement and metabolism.  
Cholesterol can enter the cell on lipoproteins through the actions of the LDL receptor, 
scavenger receptor A (SR-A) or CD36.  It can also enter as free cholesterol (FC) through 
scavenger receptor type B-1.  It can also be synthesized by the cell in the ER (orange 
area).  If the cholesterol enters as cholesteryl ester (CE) it must first be degraded in the 
lysosome to FC before it can exit from the lysosome and enter the cytoplasm.  The FC 
can then be transported out of the lysosome through the actions of NPC-1 and 2 or 
potentially through non-specific vesicular transport.  It is debated if the FC is transported 
to the plasma membrane, Golgi apparatus (light blue) or directly to the ER.  However, 
once the cell has excess FC. The FC is transported to the ER.  In the ER the FC is 
esterified though the actions of the esterase ACAT.  Once esterified the CE is 
incorporated into a cytoplasmic lipid droplet for storage.  If the cell needs additional 
cholesterol or is actively effluxing cholesterol from the cell, the CE in the cytoplasmic 
droplet can be hydrolyzed by neutral CE hydrolase (NCEH) or hormone sensitive lipase 
(HSL) or potentially other hydrolases for FC generation.  If the cell is effluxing 
cholesterol it can do so through the actions of SR-B1, ABCA1, and/or ABCG1.  
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cholesterol to HDL and is known to bind LDL and anionic phospholipids (Acton et al., 
1996; de la Llera-Moya et al., 2001; Liu and Krieger, 2002).  SR-B1 is efficient at 
mobilizing cholesterol from cells that have been cholesterol enriched, but can load cells 
with cholesterol if the cellular cholesterol level is lower than that of the interacting 
particle.  The third pathway for cholesterol efflux from cells is the ATP binding cassette 
(ABC) transporter family, mainly ABCA1 and ABCG1.  These are unidirectional 
transporters of cholesterol, which require energy, in the form of ATP hydrolysis, to 
transport the cholesterol from the plasma membrane to the accepting particle (Orso et al., 
2000).  It is also possible that ABCG1 has a role in moving cholesterol intracellularly 
because only after stimulation with LXR agonists does ABCG1 localize to the plasma 
membrane (Wang et al., 2006).  The ABC transporters interact with different molecules 
to facilitate reverse cholesterol transport.  ABCA1 is known to interact with lipid poor 
apo AI, the primary lipoprotein in HDL, to transfer cholesterol and phospholipid 
(Remaley et al., 1997; Wang et al., 2000).  Mutations in the ABCA-1 transporter result in 
Tangier’s disease, which is characterized by very low levels of high density lipoprotein 
(HDL) and significant accumulation of cholesterol in peripheral tissues (Bodzioch et al., 
1999; Rust et al., 1999).  ABCG1 primarily interacts with nascent HDL particles and 
recent data suggest that ABCA1 and ABCG1 may act synergistically to increase 
cholesterol efflux by creating a larger cholesterol enriched particle (Wang et al., 2004).  
Additionally, recent data suggest that ABCG1 may be the major transporter in reverse 
cholesterol transport (RCT) after LXR activation (Wang et al., 2006), but there have not 
been any disease phenotypes associated with the loss of ABCG1.   
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Even with the various efflux pathways present in cells, it has been shown that 
cholesterol in human foam cells is more difficult to efflux than in mouse cells (Graham et 
al., 1996; Yancey and Jerome, 2001).  However, cholesterol efflux in human cells can 
potentially be increased by increasing the expression of neutral cholesteryl ester 
hydrolase (NCEH) (Ghosh et al., 2003), which hydrolyzes cytoplasmic CEs to FC, 
making the FC available for efflux from the cell.  Furthermore, many of these efflux 
systems have been analyzed in mouse cells, which have been demonstrated to be different 
between human and mouse macrophages (Contreras and Lasuncion, 1994).  Some recent 
studies have revealed that genes in the atherosclerotic lesion are regulated such that the 
cellular cholesterol equilibrium is tilted toward cholesterol storage (Forcheron et al., 
2005).  For instance, there is an upregulation of perilipin, a protein associated with lipid 
storage, and down regulation of the efflux promoter ABCA1 (Forcheron et al., 2005). 
These data suggest that cells present in the lesion are more prone to accumulate 
cholesterol rather than effluxing it to potential extracellular acceptor particles.   
 
Modulation of cellular function by cholesterol 
 Cholesterol is required for proper membrane function in cells, and often 
cholesterol precursors, even those closely related structurally cannot substitute in cell 
functions (Yeagle, 1991).  Similarly, cells require cholesterol for growth and, when no 
exogenous cholesterol is provided, inhibition of cholesterol synthesis inhibits cell growth. 
However, growth can be restarted by cholesterol supplementation in the media (Soma et 
al., 1992).  Interestingly, supplementation with mevalonic acid, a cholesterol precursor, 
rather than cholesterol cannot restore cell growth until high concentrations are reached 
(Soma et al., 1992).  Moreover, there are multiple feedback mechanisms in place in 
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mammalian cells to assure a constant supply of cholesterol for cell growth (Brown and 
Goldstein, 1980).  However, excess FC is cytotoxic to cells (Tabas, 2002). 
Cholesterol can affect the movement and signaling of membrane proteins 
(Yeagle, 1991). Increasing the cholesterol levels in the membrane increases the thickness 
of the membrane (Bretscher and Munro, 1993), which can greatly affect the activity of 
transmembrane proteins (Bretscher and Munro, 1993).  There is evidence that cholesterol 
and phospholipids form lipid rafts within the plasma membrane, a model first proposed 
by Simons and colleagues (Simons and Van Meer, 1988).  These membrane domains 
have been demonstrated to play a role in the sorting of proteins within the plasma 
membrane (Brown and Rose, 1992).  Cholesterol has also been reported to affect the 
movement of these proteins within the plane of the membrane.  For example, the lateral 
diffusion of Ras, a small membrane bound GTPase, is slowed after plasma membrane 
cholesterol enrichment with cholesterol, but Ras diffusion is increased after overnight 
cholesterol depletion (Goodwin et al., 2005).  An increase in the membrane cholesterol of 
macrophages alters F-actin organization, which can lead to altered movement and 
signaling of the cell (Qin et al., 2005).  The change in the cytoskeleton also changes the 
ability of the cells to migrate potentially through a Rac mediated process (Qin et al., 
2005).  If the migration of the macrophages in an atherosclerotic lesion is inhibited there 
could be profound effects on the developing atheroma.  If cholesterol is removed from 
endothelial cells there is a decrease in leukocyte adhesion (Broadley et al., 1991), which, 
if it occurs in vivo, would reduce atherosclerotic lesion progression. 
Interestingly, the study by Goodwin et al. examining the effect of membrane 
cholesterol on Ras diffusion, also utilized methyl-β-cyclodextrin (MβCD), which has 
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been used extensively to alter membrane cholesterol.  This study found the lateral 
diffusion of proteins within the membrane was also altered due to membrane interactions 
of the MβCD.  The altered diffusion was potentially through a cholesterol independent 
process (Goodwin et al., 2005). In conjunction with this study it has recently been 
suggested that MβCD possibly plays a role in membrane organization and not just in the 
shuttling of cholesterol between the MβCD and the plasma membrane (Shvartsman et al., 
2006).  These studies show that additional controls are required in monitoring the effects 
of cholesterol and particles responsible for cholesterol loading on membrane properties 
and function.  These data are very interesting because MBCD are small beta-barrel like 
chemicals that have been thought to only transport cholesterol, but these data suggest that 
cyclodextrins, in general, can also bind to the membrane and alter function.   
 
Lysosomal storage disorders 
Lysosomal storage disorders (LSD)s constitute over 50 known diseases with a 
combined incidence of approximately 1:7,700 live births (Meikle et al., 1999).  These 
diseases are characterized by the loss or mutation of a lysosomal enzyme or a lysosomal 
associated protein.  The loss results in the accumulation of substrate within the lysosomal 
compartment.   Several LSDs involve malfunctions in lipid degradation and/or 
cholesterol transport.  Many of these lipid-related LSDs result in neurological defects and 
death prior to the development of cardiovascular effects.  One of the main groups of the 
LSDs that result in disruption in cholesterol transport are Niemann-Pick diseases.  There 
are three classifications of these diseases.  Type A and B involve mutations in the acid 
sphingomyelinase gene, which results in an accumulation of undegraded sphingomyelin 
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in the lysosome (Brady et al., 1966; Takahashi et al., 1992).  This sphingomyelin 
accumulation in turn leads to an accumulation of FC.  Niemann-Pick type C (NPC) 
disease is caused by a mutation in the NPC-1 protein, one of the few known cholesterol 
transporters in the cell (Ory, 2000).  This mutation also leads to an accumulation of 
cholesterol in the lysosomes of these patients (Ory, 2000).  In mucopolysaccharidosis III 
B, a different LSD, subunits of the ATP synthase and FC accumulate in the lysosomes of 
neurons of mouse cells (Ryazantsev et al., 2007).  
There have been two studies that have found that the proton pumps may be 
affected in mammalian LSDs (Bach et al., 1999; Bergmann et al., 2004).  Lysosomal pH 
is elevated in fiboblasts of mucolipidosis patients (Bach et al., 1999), an autosomal 
recessive storage disorder in which phospholipids and other substances accumulate 
undegraded in the lysosomes (Bach et al., 1999).  The causes of the elevated pH are 
unknown.  In retinal pigment epithelium cells of age-related macular degeneration 
patients,  proton pumps are inhibited, leading to an increased lysosomal pH.  
Furthermore, this inhibition is associated with lipofuscin accumulation in the lysosomes 
(Bergmann et al., 2004).   
 
Potential role of the vacuolar-ATPase in atherosclerosis 
Proton pumps biology 
Almost every biological system uses ATP as an energy source in some form.  
Throughout development this has led to the formation of several ATPases being present 
in the eukaryotic cell.  Most of these ATPases are linked to the transport of ions across 
the membrane (Gogarten et al., 1992).  In 1987 Pederson and Carafoli were the first to 
 22
give these ATPases differing designations according to their function and cellular 
location (Pedersen and Carafoli, 1987).  Many ATPase are conserved though several 
species, such that the bacterial, yeast, bovine and human vacuolar-type H+-ATPase (v-
ATPase) are all similar in structure and function (Gogarten et al., 1989; Henrik et al., 
1992).  Similarly, v-ATPase, has been conserved evolutionarily and remains very similar 
to the ATP synthase, a F-ATPase, in structure (Gogarten et al., 1992).  Yet evolutionarily 
they have developed for differing purposes, vacuolar acidification and energy generation, 
respectively.  It is believed that all of the ATPases are linked to a common ancestral gene 
that was duplicated, resulting in the differences in function (Iwabe et al., 1989).   V-
ATPases catalyze the interconversion of the proton translocation and release energy from 
ATP hydrolysis (Nelson, 1992; Forgac, 1999; Nishi and Forgac, 2002).  Most work 
regarding the v-ATPase has been performed in yeast and bacterial systems.  These 
systems have yielded important data on their structure and function as proton pumps 
(Stevens and Forgac, 1997). Zhao and colleagues have shown that distribution of the 
human osteoclast v-ATPase is sensitive to membrane cholesterol levels (Zhao and 
Vaananen, 2006). Even though the osteoclast v-ATPase is not exactly identical to the 
lysosomal v-ATPase, in that there is a slight difference in the molecular weight of the 
ATP hydrolytic domain (Chatterjee et al., 1992), the data do indicate that varying 
cholesterol concentration can affect human v-ATPases.  Additionally, the data suggest 
that the inhibition of the v-ATPase may occur in the transmembrane section.  Moreover, 
it has been shown that during human monocyte differentiation there is a four-fold 
increase in expression of several protein subunits of the v-ATPase (Lee et al., 1997; 
Wang et al., 2002).   
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In the yeast system, mutations or deletions of one of the cytoplasmic subunits of 
the v-ATPase prevent the other subunits from localizing to the vacuole.  The mutations, 
however, do not inhibit the transmembrane section of the v-ATPase from localizing to the 
vacuole (Kane, 1992; Klionsky et al., 1992).  A deletion of a component of the 
transmembrane section of the v-ATPase results in the entire complex being absent from 
the vacuole (Kane, 1992). Proteins such as regulator of v-ATPase assembly or RAVE 
have been shown to aid in the assembly of the v-ATPase (Seol et al., 2001; Smardon et 
al., 2002).  Furthermore, the v-ATPase can interact with other proteins in the endosomal 
pathway and these interactions can regulate the protein degradation pathway (Hurtado-
Lorenzo et al., 2006). Inhibition of v-ATPase using inhibitory compounds can induce a 
foam cell phenotype in cultured macrophages (Yoshimori et al., 1991).  Yet, little work 
has been done examining the possible role of the v-ATPase in the development of a 
macrophage foam cell, which have significant engorgement of the lysosomes.   
 
Vacuolar-ATPase structure and inhibition 
The v-ATPases are structurally composed of several proteins that make up two 
functional domains, the cytosolyic v1- domain and the transmembrane v0- domain.  The 
v1- domain carries out ATP hydrolysis while linking to the v0- domain through a central 
stalk region (Wilkens et al., 1999; Iwata et al., 2004; Wilkens et al., 2004; Drory and 
Nelson, 2006).  When ATP is hydrolyzed, this connection generates a proton motive 
force, which leads to the translocation of two protons through the v0- domain for every 
ATP molecule hydrolyzed (Forgac, 1999).   Yokoyama et al. demonstrated that there is a 
rotation of the transmembrane section of the ATPase during proton translocation 
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(Yokoyama et al., 2003) (Figure 3).   The rotation of the transmembrane domain in the 
membrane suggests that membrane properties could play an important role in the function 
of this protein complex.   
Inhibitors of the v-ATPase incorporate into the plasma membrane inhibiting the 
activity of the v0- or proteolipid complex (Dixon et al., 2004; Pali et al., 2004a).  These 
inhibitors often have lipid like structures.  Several of the v-ATPase inhibitors have been 
demonstrated to interact with the transmembrane section of the v-ATPase complex (Pali 
et al., 2004b), suggesting a role of the membrane properties during v-ATPase inhibition.  
Interestingly, when the v-ATPase was inhibited in some cell types there was an 
expansion of the Golgi compartment (Robinson et al., 2004), similar to what has been 
observed in our laboratory upon induction of macrophage foam cells with mildly 
oxidized LDL (Jerome et al., 1998).  These data suggest a connection between v-ATPase 
inhibition and foam cell formation.  Moreover, bafilomycin A, a specific inhibitor of the 
v-ATPase, can inhibit fusion of the phagosome with the vesicles of the late endocytic 
compartment (Dermine et al., 2001).  These data indicate how important the v-ATPase is 
to the macrophage protein degradation pathway.  Bafilomycin A has also been shown to 
cause release of TNF-α (Bidani and Heming, 1995).  TNF-α release was independent of 
cytosolic pH, but was directly related to the activity of the v-ATPase, suggesting a 
potentially important role of v-ATPase activity in inflammation (Bidani and Heming, 
1995).   
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Figure 3:  Diagram of the major components and functions of the v-ATPase.  There are 
two domains of the v-ATPase.  The cytoplasmic domain of the v-ATPase is termed the 
v1-domain and consists of three subunits A and B each.  The transmembrane domain is 
termed the v0-domain and consists of between 9 and 12 subunits labeled subunits c, c’, 
and c”.  The v1-domain is responsible for ATP hydrolysis.  The ATP hydrolysis generates 
a force through the stalk region (subunits H and a) leading to a rotation of the v0- domain.  
The rotation of the v0- domain generates a proton motive force leading to the pumping of 
two hydrogen ions into the lysosomal lumen. Diagram adapted from Manolson 
(Manolson, 2006). 
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Effect of lipid on the ATPases 
 With the variety of ATPases present in the cell and slight differences between 
species, studying the effect of lipids on these structures has produced controversial results 
(Yeagle et al., 1988; Chung et al., 2003; Crider and Xie, 2003).  One unifying theme is 
 that increased cellular cholesterol levels often have a detrimental effect on the activation 
of these pumps (Yeagle, 1991).  Yeagle and colleagues demonstrated that the Na+-K+-
ATPase in the kidney has little activity outside the cholesterol composition of the native 
membrane (Yeagle et al., 1988).  Both increasing and decreasing the cholesterol 
concentrations significantly reduces activation (Yeagle et al., 1988).  Similarly, in human 
erthrocytes data indicate the Ca2+-ATPase has a bell shaped activation curve that 
correlates with cholesterol levels (Grunze et al., 1980).  These studies suggest that there 
is a specific cholesterol concentration range in which the v-ATPase is active.  Recent 
studies have shown that cholesterol directly inhibits the Ca2+-ATPase in the sarcoplasmic 
reticulum in human cells through increasing the order of the membrane lipids (Li et al., 
2004).   In contrast to these data, it has also been demonstrated that sphingolipids, a 
group of phospholipids that interact with cholesterol in the membrane, are required for 
the formation of a functional v1- domain of the v-ATPase (Chung et al., 2003).  Since 
there are several trafficking steps after assembly of the v-ATPase, it would be interesting 
to determine if this could be a sorting effect or if the pumps were active in this 
environment. 
In the bovine system a direct relationship has been demonstrated between lipid 
composition and the activity of the v-ATPase (Xie et al., 1989; Xie et al., 1993; Crider 
and Xie, 2003).   To activate the v-ATPase maximally, a phospholipid mixture was 
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required; lipid vesicles composed of a single phospholipid resulted in inhibition of 
activation (Crider and Xie, 2003).  High cholesterol concentration inhibit v-ATPase 
activation (Xie et al., 1993; Crider and Xie, 2003).  Mattsson et al. demonstrated that 
osteoclast H+-ATPases are very similar to v-ATPases, in both structure and function, and 
they are subject to inactivation by cholesterol (Mattsson et al., 1994).  Additionally, 
inhibiting cholesterol movement in these cells with U1866A inhibits the movement of the 
osteoclast ATPases (Zhao and Vaananen, 2006).  Finally, D’Souza and colleagues have 
shown that reconstitution of the lysosomal membranes is a valuable way in which to 
evaluate proton pump biology and that cholesterol and phospholipid are vital components 
in generating proper activation of the v-ATPase (D'Souza et al., 1987).  Utilizing 
modifications of this reconstituted system with bacterial or bovine v-ATPases, data 
indicate that phospholipid and cholesterol content can regulate the activity of the proton 
pump and other transport systems (Newman and Wilson, 1980; Ambudkar and Maloney, 
1986).   
Knowing that cholesterol can affect v-ATPase activity, there could also be a 
direct link to cholesterol in the development of foam cells because cholesterol alters the 
actin cytoskeleton in macrophages (Qin et al., 2005).  Inhibition of actin polymerization 
has also been linked to improper trafficking of the v-ATPase (Beaulieu et al., 2005).  
Therefore, these data indicate a possible link to the inhibition of v-ATPase activation and 
foam cell formation.  Yet little has been done to directly examine how v-ATPase activity 
and trafficking is affected by lipid accumulation in macrophages, such as is associated 
with foam cell formation.   
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Rationale for current studies 
Lysosomes have long been implicated in the development of the macrophage 
foam cell in atherosclerotic lesions.  However, they remain an understudied aspect of 
atherosclerosis research.  Several laboratories have demonstrated that physiologic lipid 
particles lead to lysosomal accumulation as foam cells develop and the cholesterol in 
these particles is trapped within the lysosomes.  However, earlier data from this 
laboratory demonstrated that early in foam cell development the lysosomal hydrolysis is 
functional.  While there is active hydrolysis of the CEs, the FC generated in the 
lysosomes is unable to egress from the lysosomes.  This supports the hypothesis that 
atherosclerosis may be a lysosomal storage disorder.  After this brief period of active 
hydrolysis, there begins to be an inhibition of hydrolysis of the CEs such that they begin 
to accumulate undegraded within the lysosomes.  Additionally, cholesterol and 
phospholipids have been demonstrated to affect the activity of the v-ATPase, the major 
pumps responsible for generating the acidic, active lysosomal environment.  To date no 
studies have analyzed a potential role for malfunction of these pumps in the development 
of macrophage foam cells.  The effect of cholesterol induced inhibition of the v-ATPase 
could be exacerbated by these cell having as much as 1000 micrograms of cholesterol per 
milligram of cell protein, approximately 500 times the levels of resting macrophages. The 
potential mechanism of this inhibition of lysosomal hydrolysis and induction of 
lysosomal dysfunction is presented in this research. 
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 CHAPTER II 
 
Effect of Cholesterol Accumulation on Lysosomal Activation and 
Function 
 
Introduction 
The hallmark of an atherosclerotic lesion is the presence of macrophage foam 
cells, which are large lipid engorged cells.  In later stages of lesion development, there is 
a large accumulation of lipid within the lysosomes of the foam cells (Peters et al., 1972; 
de Duve, 1974; Peters and de Duve, 1974).  Utilizing a tissue culture model of foam cell 
formation, this lysosomal accumulation can be mimicked with atherogenic CE-containing 
particles such as mildly ox-LDL, agg-LDL and CE-enriched phospholipid dispersions 
(Jerome and Cash, 1995; Jerome et al., 1998; Yancey and Jerome, 1998; Griffin et al., 
2005).  Moreover, these particles produce a sterol accumulation (both FC and CE) similar 
to that seen in lesions (Jerome, 2006). More recently, it has been demonstrated that 
mildly ox-LDL, agg-LDL, and DISP can produce a general inhibition of lysosomal CE 
hydrolysis, suggesting an explanation for the lysosomal sterol accumulation (Griffin et 
al., 2005). One alteration that could explain the inhibition of CE hydrolysis would be an 
unfavorable change in the lysosome/late endosome environment, such that the pH 
increases beyond that at which the lysosomal lipases can function.   The primary 
lysosomal lipase responsible for hydrolysis of lipoprotein CE is lysosomal acid lipase 
(LAL). This enzyme, as is suggested by the name, requires an acidic pH to function, with 
a peak activity between pH 3.8-4.0 and very little activity above a pH of 4.5 (Sando and 
Rosenbaum, 1985b).   We, therefore, sought to determine if there was a change in 
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lysosomal pH as cellular and/or lysosomal cholesterol levels increased. To determine pH, 
we used the dye LysoSensor Yellow/Blue DND-160, which fluoresces yellow at acid pH 
but, has a significant blue shift as pH approaches neutrality (Diwu et al., 1999; Lin et al., 
2001). Intracellular vesicles were classified as active if they had a pH below 4.8 and 
inactive if their pH was above 4.8. This pH was chosen because it is above that usually 
associated with lysosomes and well above the narrow pH range of human lysosomal acid 
lipase.  
 
Experimental procedures 
Materials 
THP-1 monocytes were obtained from ATCC (Manassas, VA).  Phospholipids for 
the production of lipid dispersions were obtained from Avanti Polar Lipids (Birmingham, 
AL). All other chemicals were obtained from Sigma (St. Louis, MO).  Tissue culture 
supplies were obtained through VWR International (St. Louis, MO).   
 
Cell culture   
THP-1 monocytes were cultured and differentiated to macrophages as described 
previously (Yancey et al., 2002).  Briefly, monocytes were plated at a density of 0.75 X 
106 cells / ml.  After differentiation into macrophages with Phorbol 12-myristate 13-
acetate (50 µg / ml) for three days, cells were cleared of residual triglyceride by 
incubation with 4 mg / ml fatty acid free-BSA in media containing 1% FBS.  Cells were 
loaded with modified lipoproteins, DISP (75-100 µg / ml), or magnetic beads (100 µl 
beads/ 30 ml media)(Invitrogen, Carlsbad, CA) in media containing 1% FBS.  We tested 
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for loss of cells during culture by daily microscopic analysis of cell numbers and by 
protein levels per dish. In the time frame of the experiments, significant cell or protein 
loss was not observed. 
 
Cholesterol analysis 
Cholesterol loading of cells was confirmed by extracting cellular lipids into 
isopropanol and quantifying FC and CE content by gas-liquid chromatography (GC) as 
previously described (Griffin et al., 2005).  Briefly, cells were rinsed twice with PBS with 
all PBS removed after the final wash.  The cells were then dried by inverting the dishes 
and evaporating any residual PBS at room temperature.  After drying was complete, 
isopropanol was added to each well.  To this cholesterol methyl ether (CME) was added 
as an internal standard.  The cellular lipid was extracted overnight in a humid chamber at 
room temperature.  The isopropanol was then removed and divided between two tubes for 
analysis of free and total cholesterol.  The isopropanol was dried at 37 °C under a stream 
of nitrogen gas.  Once dried the samples for total cholesterol had 100 µl of 3:1 
isopropanol: tetramethylammonium hydroxide  added and vortexed to solubilize the lipid.  
These tubes were placed in a heat block equlibriated to 80 °C for 15 minutes to cleave the 
cholesterol ester bond and provide total cholesterol levels.  The tubes were cooled and 
then both free and total cholesterol samples received 50 µl tetrachloroethylene  and 
vortexed.  Then 150 µl of deionized water was added and vortexed.  The tubes were 
centrifuged and the bottom organic layer removed.  The organic layer was dried under 
nitrogen gas and then resolubilized in carbon disulfide for injection on the GC.  For GC 
separation and detection a 30 m x 0.530 mm HP-50+ capillary column was used in 
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conjunction with a flame ionization detector.  For standardization of the column a 1:1 
sample of FC:CME was used.  The value of free and total cholesterol was calculated 
using the area of the cholesterol peak divided by the CME peak multiplied by the column 
standard value.  These values were then normalized to the cellular protein values, which 
were determined using the method of Lowry et al. (Lowry et al., 1951).  To obtain the 
level of esterified cholesterol the values obtained for the FC was subtracted from the 
value obtained for the total cholesterol. 
 
LDL isolation and modification 
LDL was isolated from plasma of healthy, fasted, normolipidemic subjects using 
a standard NaCl density isolation, reported previously (Yancey and St Clair, 1992).  
Blood was obtained using procedures approved by the human subjects Institutional 
Review Board.  LDL was isolated at a density of 1.006 < d < 1.063.  After isolation, the 
LDL was extensively dialyzed against 0.9% NaCl with 0.3 mM EDTA for 72 hours (3 
changes), stored under nitrogen, and maintained at 4 oC.  Protein was determined by the 
method of Lowry et al. (Lowry et al., 1951).  LDL acetylation was carried out using a 
standard acetic anhydride-sodium acetate acetylation on ice (Basu et al., 1976).  To 
oxidize LDL, EDTA was first removed by dialysis in 0.9% NaCl for 36 hours (3 
changes) at 4 oC, and then the LDL was dialyzed for an additional 1 hr at room 
temperature in 1 L of 0.9% NaCl.  Following this, 1 ml of a 20 mM CuSO4 was added 
(final Cu+2 concentration 10 µM) and allowed to equilibrate without stirring for the first 
hour and dialyzed for an additional 3-5 hours with stirring.  Oxidation was terminated by 
placing the LDL in a solution of 0.9% NaCl with 1 mg / ml EDTA (pH 7.4).  After 1 hr at 
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room temperature, the solution was placed at 4 oC for 12 hr.  EDTA was equilibrated to 
0.3 mM by dialysis in 0.9% NaCl and 0.3 mM EDTA for 36 hr with 3 changes.  Only 
mildly ox-LDL was used, as determined by TBARS between 30-50 ng / mol and minimal 
conjugated diene formation (Bird and Draper, 1984). LDL aggregation was performed by 
first vortexing the LDL, under nitrogen, for 1 minute or until the LDL became cloudy.  
The vortexed LDL was then placed on ice and sonicated, using a probe type sonicator 
(Branson Digital Sonicator, Danbury, CT) at 50% power for 20 min using 10 sec pulses.  
The aggregates were then passed through a 0.45 µm filter to remove any remaining large 
or chain aggregates.  The small size of the agg-LDL was confirmed by negative stain 
transmission electron microscopy (TEM).  Particle size ranged from 40-250 nm.  All 
modified LDL was analyzed further for uniformity by agarose gel electrophoresis and 
checked for degree of oxidation by TBARS and conjugated dienes as described (Bird and 
Draper, 1984).  Agg-LDL and ac-LDL were used only if no oxidation was detected.  
 
Lipid dispersion production and experimentation 
CE-rich lipid dispersions (DISP) were produced as described previously (Minor et 
al., 1991) by mixing phosphatidyl choline, phosphatidyl serine, and cholesteryl oleate 
(1:0.1:30 by weight) in RPMI 1640 media.  The resulting mixture was sonicated for 20 
minutes at 50% amplitude and the size and uniformity of the dispersions determined by 
negative stain TEM.  DISP sizes ranges from 60-200 nm.  We confirmed that the DISP 
were not oxidized by measuring TBARS and conjugated diene formation.   
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Cellular staining 
The locations of neutral lipid and FC accumulation in cells were determined by 
staining with Nile red (Greenspan et al., 1985) and filipin (Kruth, 1984), respectively. 
Anti-human lysosomal associated membrane protein 1 (LAMP-1) antibody (BD 
Biosciences; San Jose, CA) staining was used as a marker for lysosomes / late 
endosomes. The method for immunofluorescent LAMP-1 staining has been previously 
described (Griffin et al., 2005). Controls included replacing the primary antibody with 
pre-immune serum and leaving the primary antibody out of the protocol. LysoSensor 
Yellow/Blue DND-160 staining (Molecular Probes, Eugene, OR) was used to determine 
changes in the lysosomal pH (Diwu et al., 1999; Lin et al., 2001).  Cells were washed two 
times in PBS and the dye was added to cells at a concentration of 5 µM in media 
containing 1% FBS.  All images were collected within 10 minutes following the 
placement of dye on the cells to avoid artifacts produced by the alkaline properties of the 
dye. As a positive control, we stained macrophages after incubation with polystyrene 
beads rather than lipoprotein. This will induce a lysosomal expansion in the absence of 
lipid accumulation.  Thus the number and size of the lysosomal fraction, compared to 
cellular area, should increase.  For simplicity, in the following descriptions, we will use 
the generic term lysosome to refer to LAMP-1 positive hydrolytic compartments 
(lysosomes/late endosomes) since both appear to be equally affected.  
 
Microscopy  
A Zeiss Axioplan Imaging E fluorescence/brightfield microscope (Zeiss, 
Germany) was used for all light microscopy.  Images were collected using a Photometrics 
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Coolsnap HQ digital camera with a cooled CCD chip (Roper Scientific, Tucson, AZ).  
Image analysis was conducted using MetaMorph imaging software (Universal Imaging, 
Downingtown, PA).  To determine changes in the number of active lysosomes, a grid was 
placed on each image as an unbiased selector of cells to evaluate. The number of vesicles 
with pH below 4.8 (active lysosomes) and above 4.8 (inactive lysosomes) were counted 
based on intensity of the blue and green channels compared to known pH standards. This 
pH value was chosen because the lysosomal acid lipase should have no activity above a 
pH of 4.8 and this value is above the pKa of LysoSensor such that there is a significant 
blue shift in the fluorescence of the probe. The vesicles in at least 20 cells per condition 
from 3 experiments were counted. The data from the different experiments were 
combined to obtain a mean and standard error.  To test for significance, ANOVA with 
Tukey’s posttest was performed using GraphPad Prism software (San Diego, CA). To 
quantify the percentage of vesicles in macrophages that were lysosomes/late endosomes, 
we used Nomarski differential interference microscopy to identify vesicles. A grid of 
points overlaid on the image was used to arbitrarily select vesicles for analysis and 
fluorescence microscopy was used to determine if the selected vesicles were LAMP-1 
positive. One hundred to two hundred vesicles were assayed for each condition.  
 
Western blotting 
After incubation with loading vehicle for the indicated times, cells were washed 
three times in PBS.  Cells were lysed in 2x loading buffer (0.1 M DTT, 20 % glycerol, 
TRIS pH 6.8, 1%SDS), loaded on a 4-12% gradient Bis-Tris SDS-PAGE gel (Invitrogen, 
Carlsbad, CA), run for 15 min at 100 V and 90 min at 120 V and transferred to 
 36
nitrocellulose for 90 min at 25 V.  Blots were stained using a primary antibody to apo B 
(dilution 1:20000) (a gift from Dr. Larry Swift, Vanderbilt University), v-ATPase H-
subunit (1:1000) (Santa Cruz), or β-actin (1:5000) (Sigma, St. Louis, MO).  Secondary 
HRP conjugated antibodies were obtained from Promega (Madison, WI) and detected 
using ECL (PerkinElmer Life Sciences, Boston, MA) and Kodak Biomax film.   
 
Results 
The inactivation of lysosomes correlates temporally with the inhibition of CE  hydrolysis  
and the accumulation of lysosomal CE (Yancey and Jerome, 1998; Griffin et al., 2005); 
suggesting generalized change in the lysosome. Lysosomal enzymes require an acidic pH 
to be active.  Therefore, failure to maintain an active pH would inhibit the lysosomal 
hydrolysis of other molecules as well. To test this, we determined whether degradation of 
the apo B component of mildly ac-LDL, ox-LDL, or agg-LDL particles was also 
inhibited (Figure 4). Cells incubated with ac-LDL for up to 6 days did not accumulate 
immunostainable apo B. The lack of apo B staining was not due to a lack of uptake of ac-
LDL since cells treated with both ac-LDL and ox-LDL had equivalent cholesterol levels. 
This indicates that the ac-LDL was taken up by the macrophages and delivered to 
lysosomes where the lipoprotein was actively degraded within the cells. This is consistent 
with previous studies from our laboratory and others (Basu et al., 1976; Yancey and 
Jerome, 1998; Yancey et al., 2002). The lack of staining was also not due to a lack of 
immunoreactivity of the apo B following acetylation since apo B from ac-LDL was 
readily detectable by our antibody prior to incubation of the ac-LDL with cells (Figure 4). 
In contrast to ac-LDL, macrophages incubated with mildly ox-LDL or agg-LDL  
 37
  
 
 
 
 
 
Figure 4: Apolipoprotein B accumulation in THP-1 macrophages.  THP-1 macrophages 
incubated with mildly ox-LDL (75 µg / ml) for 1 day (lane 4), 3 days (lane 5), or 6 days 
(lane 6) or agg-LDL (75 µg / ml) for 1 day (lane 7), 3 days (lane 8), or 6 days (lane 9) 
and then blotted for the presence of apo B showed progressive accumulation of immune 
reactive apo B (apo B and fragments (frag)).  In contrast, THP-1 macrophages incubated 
with ac-LDL (75 µg / ml) for 1 day (lane 1), 3 day (lane 2), or 6 days (lane 3) showed no 
increase in apo B staining over control (lane 10) levels indicating that apo B present in 
ac-LDL was efficiently degraded.  β-actin was used as a load control. Ac-LDL (5 µg) 
(lane 11) was diluted in loading buffer and run according to the methods section to 
confirm detection of apo B in ac-LDL.  It was immuno-blotted for the presence of apo B 
and two bands appeared that were identical to the unmodified LDL used in the 
acetylation procedure. 
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showed a time-dependent accumulation of immunostainable apo B and apo B fragments, 
with agg-LDL producing a greater intracellular accumulation than ox-LDL (Figure 4). 
The lack of CE hydrolysis and apo B degradation suggest a generalized inhibition 
of lysosomal function.  Since lysosomes require an acidic pH to function properly, the 
lysosomal pH was analyzed using LysoSensor Yellow/Blue.  As a positive control for 
active lysosomes, macrophages were treated with polystyrene beads to induce a 
lysosomal engorgement without a subsequent increase in lysosomal lipid.  The 
macrophages were incubated for 24 hours with polystyrene beads.  They were then 
washed and incubated in media alone for an additional 6 days.  These macrophages did 
not show a change in pH over time, indicating that time duration was not associated with 
an increase in lysosomal pH (Figure 5).  
In untreated cells or polystyrene bead treated (Figure 5), the majority of vesicles 
in macrophages exhibited an active pH. Similarly, cells treated with mildly ox-LDL for 
24 hours still contained predominantly active lysosomes (Figure 6A).  However, after 7 
days of mildly ox-LDL treatment (and cellular cholesterol levels increasing above 150 µg 
/ mg cell protein) the majority of vesicles in the cells had a pH above 4.8 (Figure 6B). To 
determine if the lysosomal neutralization was dependent upon oxidized lipids, we 
investigated the effect of cholesterol loading from agg-LDL or DISP, both of which 
lacked oxidized lipids, on lysosomal pH.  Cells loaded with small agg-LDL (Figure 6C) 
and DISP (Figure 6D) (both of which reach cholesterol levels in excess of 250 µg / mg 
cell protein) showed increases in lysosomal pH.  In these macrophages the majority of 
vesicles had a pH above 4.8 by day 7. The lysosomal neutralization did not occur in cells 
treated with ac-LDL (Figure 6E), even though these cells also obtained total cellular  
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Figure 5: LysoSensor Yellow/Blue DND-160 staining of a THP-1 macrophage incubated 
with polystyrene beads for 24 hours and then incubated for an additional 6 days in media 
alone.  This image demonstrates that lysosomes are long-lived and, without cholesterol 
accumulation, do not lose activity throughout the course of the study.  
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cholesterol levels above 150 µg / mg cell protein. The major difference between ac-LDL-
treated cells and those treated with other lipid particles was that ac-LDL-treated cells 
accumulated cholesterol in cytoplasmic CE droplets and lacked lysosomal sterol (FC and 
CE) accumulation. This observation concurs with previous studies showing that 
cholesterol does not accumulate in lysosomes when ac-LDL is the loading vehicle 
(Brown et al., 1979; Yancey and Jerome, 1998).  To verify that our methods could detect 
an increase in pH in the presence of ac-LDL, we incubated cells in the presence of ac-
LDL and 50 µM chloroquine, a lysomotrophic agent that increases the lysosomal pH. 
These cells demonstrated large lysosomes, indicative of chloroquine inhibition of 
lysosome function, and the LysoSensor Yellow/Blue fluorescence indicated a pH above 
4.8 (Figure 6F), confirming that ac-LDL does not interfere with our ability to detect 
increases in lysosome pH.  Additionally, the macrophages incubated with polystyrene 
beads did not exhibit an increase over the seven day time course.  These data, along with 
the ac-LDL data, indicate that time duration was not the cause of the pH increase.  
To expand our analysis, we quantified changes in the number of active or inactive 
vesicles in cells with the various treatments over time. Within the initial 24 hours, 
lipoprotein treatment did not change the number of active lysosomes compared to 
controls and greater than 85% of the intracellular vesicles showed pH below 4.8 (Figure 
7).  After 72 hours of treatment, however, there was a blue shift in fluorescence such that, 
depending upon the treatment, only 45-60% of the vesicles now showed an active pH. 
The number of inactive lysosomes continued to increase with time and after 7 days of 
treatment with mildly ox-LDL, DISP, or agg-LDL the majority (>85%) of the vesicles 
were inactive (Figure 7).  The shift in vesicle pH was also not due to loss of lysosomes as  
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Figure 6:  LysoSensor Yellow/Blue DND-160 staining of macrophages.  (A)  After 24 
hours of treatment with 75 µg / ml mildly ox-LDL, lysosomes remain active (pH<4.8) as 
indicated by the yellow fluorescence pattern.  (B)  After 7 days of incubation with mildly 
ox-LDL, most lysosomes show a predominately blue fluorescence pattern indicating a 
rise in pH to near neutrality.  (C)  Similar lysosome pH increases are observed in THP-1 
macrophages incubated for 7 days with 75 µg / ml agg-LDL.  (D) Treatment of 
macrophages for 7 days with 60 µg CE / ml DISP also resulted in an increase in lysosome 
pH.  (E)  The increase in pH is not observed in cells treated with 75 µg / ml ac-LDL for 3 
days.  (F) To verify our ability to detect lysosomal neutralization in the presence of ac-
LDL, macrophages were incubated with 75 µg / ml ac-LDL for 24 hr in the presence of 
50 µM chloroquine, a lysomotrophic agent that raises the lysosomal pH. Magnification= 
500X. 
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evidenced by positive staining for the lysosome/late endosome marker LAMP-1.  For 
instance, in a representative experiment, 73% of vesicles in untreated cells showed 
positive staining for LAMP-1. This increased to 81% after 2 days of incubation with 75 
µg / ml DISP and 84% at day 6. In a separate experiment, 64% of vesicles were LAMP-1 
positive at day 0. This increased to 86% and 84%, respectively, with 2 or 6 day 
incubation with 100 µg / ml DISP. A similar pattern was seen when macrophages were 
incubated with 75 µg / ml agg-LDL. With agg-LDL, 66% of vesicles were LAMP-1 
positive at day 0, 72% of vesicles were positive after 2 days of incubation and 90% were 
positive after 6 days. These data indicate that the majority of the vesicles in macrophages, 
even untreated macrophages, represent lysosomes/late endosomes and most of these 
showed increased pH in conjunction with lysosome FC and CE accumulation.    
The DISP data suggests that cholesterol, phospholipids, or hydrolytic products of the two, 
directly or indirectly mediated the inhibition of lysosomal pH, since these are the only 
components in the DISP.  To test whether unesterified cholesterol was a mediating factor, 
cells were treated with ac-LDL in the presence of progesterone. Progesterone treatment 
has been shown to produce FC accumulation in the lysosomes of ac-LDL-treated cells by 
inhibiting the trafficking of unesterified cholesterol out of the lysosomes (Butler et al., 
1992; Lange, 1994; Mazzone et al., 1995).  We analyzed the lysosomal pH using 
LysoSensor Yellow/Blue.  
THP-1 macrophages were incubated with 100 µg / ml ac-LDL in the presence of 
10 µg / ml progesterone for either 24 hours or 72 hours.  After 24 hours incubation with 
ac-LDL, the cholesterol level in the macrophages ranged from 40-50 µg cholesterol per 
mg cell protein, which is an approximate doubling of cholesterol compared with  
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Figure 7: Quantification of the percent of vesicles showing an active pH (pH 
<4.8) lysosomes after treatment with various CE sources.  After one day of treatment 
with mildly ox-LDL (75 µg / ml), agg-LDL (75 µg / ml), or lipid dispersions (60 µg CE / 
ml), most vesicles exhibit an active pH.  However, after 3 days of loading with each type 
of particle there was a decrease in the number of active lysosomes.  This trend continued 
such that less than 25% of the lysosomes exhibited an active pH after 7 days.  However, 
Untreated (control) and macrophages treated with 75 µg / ml ac-LDL, which had similar 
total cholesterol levels to the ox-LDL treated cells, did not undergo a change in the 
number of active lysosomes over the 7 day period. Asterisks (*) indicate means which 
were statistically different (p<0.001) from those of untreated control cells. 
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 untreated macrophages.  The 72 hour incubation with ac-LDL induced cholesterol levels 
between 90-100 µg; a four to five times increase in total cellular cholesterol.  After the 24 
hour incubation with ac-LDL and progesterone there was an increase in lysosomal pH 
above 4.8 in almost all (>90%) lysosomes (ac+P, Figure 8A and Figure 9A).  However, 
after removal of the progesterone block, the lysosomes of these cells rapidly regained 
their activity, during incubation in media alone for an additional 24 hours (ac+P+w, 
Figure 8A and Figure 9C).  It is important to note that neither ac-LDL alone (Figure 5) 
nor progesterone treatment alone (P, Figure 8) resulted in a significant inactivation of 
lysosomes.  A 24 hour wash in media alone had no significant effect on lysosomes of 
cells treated with progesterone alone (P+w, Figure 8). Since the inactivation of lysosomes 
with short-term progesterone treatment was reversible, we sought to determine if longer-
term treatment with progesterone would lead to an irreversible change in lysosomes.  
Cells that had been incubated with ac-LDL in the presence of progesterone for 72 hours 
also primarily contained inactive lysosomes (>90%) (ac+P, Figure 8B and Figure 9B).  
To examine if the lysosomes were able to return to an active pH, the progesterone block 
was removed through washing and incubating the macrophages in media alone for 72 
hours.  After the 72 hour incubation in media alone, some of the lysosomes were able to 
reestablish an active pH, but the majority (>60%) retained an inactive pH (ac+P+w, 
Figure 8B and Figure 9D).  
To confirm that progesterone treatment led to an accumulation of FC in 
lysosomes, we used filipin staining to identify unesterified cholesterol in cells.  Ac-LDL 
alone did not produce FC accumulation in vesicles. However, macrophages that were 
loaded with ac-LDL in the presence of progesterone for 24 hours had numerous  
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 Figure 8: Effect of ac-LDL and progesterone treatment on percentage of vesicles 
having an active (pH < 4.8) lysosome pH. (A)  THP-1 macrophages were treated for 24 
hours in media with 10 µg / ml progesterone (+P) alone or in conjunction with 100 µg / 
ml ac-LDL (ac+P).  Most lysosomes in cells treated with progesterone alone had an 
active pH (pH<4.8). The progesterone-alone cells were similar to control cells receiving 
no treatment and to cells treated with ac-LDL alone (Figure 2).  Progesterone treatment 
followed by 24-hour incubation in media alone (P+w) had little effect on the number of 
active lysosomes.  However, treatment of cells with ac-LDL (as a source of CE) in the 
presence of progesterone significantly (** p<0.001) reduced the number of active 
lysosomes.  This effect was reversed by removing the progesterone block through 
incubation for 24 hours in media alone (ac+P+w).  (B)  Similar responses were seen 
when cells were treated for 72 hours with progesterone alone (P), progesterone plus 
washout (P+w), or ac-LDL in the presence of progesterone (ac+P) with a significant (** 
p<0.001) reduction in the number of active lysosomes seen only when ac-LDL provided a 
source of cholesterol. However, unlike the 24 hour incubations, macrophages that were 
incubated in media alone for an additional 72 hours after ac-LDL and progesterone 
treatment (ac+P+w) still had a significant reduction in the number of active lysosomes 
compared to control cells (* p<0.05).   
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Figure 9:  LysoSensor Yellow/Blue DND-160 staining of THP-1 macrophages incubated 
with ac-LDL in the presence of progesterone for 24 hours resulted in most lysosomes 
having an inactive pH (S1A).  Incubation with ac-LDL and progesterone for 72 hours 
produced a similar decrease in number of active lysosomes to that seen after 24 hours 
(S1B).  A 24 hour wash of cells incubated with ac-LDL and progesterone for 24 hours 
restored most lysosomes to an active pH (S1C).  However, even a 72 hour wash of cells 
incubated with ac-LDL and progesterone for 72 hours only restored some but not all 
lysosomes to an active pH (S1D).  
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intracellular sites of FC accumulation (Figure 10A). These were of a size, number, and 
location consistent with our previous studies demonstrating FC accumulation in 
lysosomes (Jerome et al., 1998; Griffin et al., 2005).  The filipin studies also 
demonstrated that there was near complete loss of intracellular FC stores after a 24 hour 
chase in media alone (Figure 10C).  Cells that were treated for 72 hours with ac-LDL and 
progesterone accumulated even larger amounts of intracellular cholesterol (Figure 10B). 
In contrast to cells incubated for 24 hours, cells incubated with ac-LDL and progesterone 
for 72 hours retained much of the FC within intracellular stores even after the block was 
removed (Figure 10D).  Untreated cells show little intracellular filipin staining, rather the 
staining primarily localized to the plasma membrane (data not shown).  Taken together, 
our data suggests that lysosomal unesterified cholesterol accumulation plays a role in 
inhibition of lysosomal acidification.   
 
Discussion 
General discussion 
Lysosomes are specialized organelles, which are responsible for degrading material, both 
endocytosed and intracellular, into components that can either be utilized by the cell or 
released into the surrounding space for use by other cells.  Inhibiting this key organelle 
could have severe consequences to the biology of the cell.  We have shown in the 
preceding section that as macrophages take up large amounts of physiologic CE-
containing lipid particles there is an inhibition of proper lysosomal acidification.  This 
inhibition corresponds with a decrease in lysosomal function through the accumulation of 
undegraded apo B and with the previously demonstrated accumulation of lipoprotein  
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Figure 10: Filipin staining for FC in macrophages treated with progesterone and ac-LDL.  
Cells treated with 100 µg / ml ac-LDL and 10 µg / ml progesterone for 24 hours (A) and 
72 hours (B) had many FC enriched vesicles with a size and distribution pattern 
consistent with macrophage lysosomes.  However, removal of the progesterone block 
after 24 hours of ac-LDL / progesterone-treatment resulted in an almost complete 
reduction in intracellular FC stores after 24 hours (C).  In contrast, intracellular 
accumulations of unesterified cholesterol were not completely removed when cells 
treated with ac-LDL and progesterone for 72 hours were allowed even a 72 hour washout 
period in media alone. (D). Magnification= 300X. 
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derived CE (Yancey and Jerome, 2001; Griffin et al., 2005).  Additionally, lysosomal 
inhibition occurring in the presence of agg-LDL and DISP rules out that this is an effect 
of exogenously oxidized lipids and suggests that the inhibition is a more generalized 
component of the particle.  Why these particles differ from ac-LDL is still unresolved.  
The lysosomal inhibition could lead to an expansion of the lysosomal 
compartment because material is still being delivered to the lysosomes, but not allowed to 
exit. This concept corresponds with the notion that atherosclerosis has features of an 
acquired lysosomal storage disorder (Peters et al., 1972; Jerome, 2006).  The 
accumulation of undegraded lysosomal contents could have dire consequences to the cell 
biology of the macrophage and could potentially lead to the rupture of the cell.  The 
rupture of the macrophage foam cells could exacerbate atherosclerotic lesion formation 
through the formation of the necrotic core.   Ac-LDL is a non-physiologic modified 
lipoprotein particle, which is capable of loading large amounts of cholesterol into the 
macrophage.  While ac-LDL is non-physiologic, the fact that it can load significant 
amounts of cholesterol into the non-lysosomal compartments of the cell makes it a useful 
particle for investigating modified LDL-derived cholesterol trafficking and the effects of  
general cellular sterol accumulation on lysosome function.  Since our agg-LDL and DISP 
data suggest a generalized component of the particle is responsible for lysosome 
inhibition, we monitor the effects of pharmacologically produced lysosomal FC 
accumulation on lysosomal function using progesterone treatment in the presence of ac-
LDL loading.  Sequestering FC in the lysosome resulted in a rapid and significant  
decrease in the number of active lysosomes.  Conversely, in macrophages with a previous 
doubling of the cellular cholesterol levels, lysosomal inactivation was reversible after a 
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washout period and cholesterol was no longer sequestered in the lysosomes.  However, 
cells with higher cholesterol concentrations (4-5X that of controls) were not able to 
reactivate lysosomes.  These data suggest that there may be a threshold level of 
cholesterol, which, once reached, permanently blocks lysosomal function. This would 
have serious implications in an atherosclerotic lesion because the macrophages present 
are continuously exposed to lipid particles and once the threshold is reached the 
macrophages would be incapable of recovery.  This is potentially why, in some models of 
atherosclerosis, pre-existing lesions were unaffected by a regression diet (Jerome and 
Lewis, 1990). 
 
Lysosomal inhibition with physiological lipid particles 
 Lysosomal lipid accumulation is a ubiquitous but under explored feature of 
macrophage foam cells in atherosclerotic lesions (Jerome, 2006).  It is probably most 
prevalent at later stages of lesion development rather than in the early, fatty streak 
development (Jerome and Lewis, 1987). Previously, we showed that cells treated in 
culture with mildly ox-LDL, agg-LDL, or CE-rich dispersions exhibit significant 
lysosomal free and esterified cholesterol accumulation similar to that seen in lesions 
(Yancey and Jerome, 1998; Griffin et al., 2005).  There is ample evidence that ox-LDL, 
agg-LDL, and CE-containing lipid particles are present in atherosclerotic lesions.  These 
particles are internalized by macrophages and thus deliver sterol to lysosomes (Ylä-
Herttuala et al., 1989; Chao et al., 1990; Rosenfeld et al., 1991; Guyton and Klemp, 1994; 
Kruth, 1997).  However, despite the variety of loading vehicles present in the artery wall, 
foam cells in advanced lesions have remarkably similar phenotypes, including substantial 
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free and esterified cholesterol accumulation in lysosomes (Jerome, 2006). One 
explanation for this would be that there is a key component common to all these 
atherogenic particles that produce a similar defect in the lysosomes of most foam cells.  
Our previous studies indicate that, in tissue culture, the CE accumulation was, in part, the 
result of failure of lysosomal lipoprotein CE hydrolysis (Yancey and Jerome, 2001; 
Griffin et al., 2005). However, both FC and CE accumulated in lysosomes and so 
differentiating the effects of lysosomal CE vs. FC on hydrolysis was not possible in those 
studies. In contrast to this, ac-LDL did not exhibit this failure of lysosomal hydrolysis 
(Yancey and Jerome, 2001).  In the current study, using progesterone to specifically 
inhibit FC egression from lysosome during treatment with ac-LDL, we show that 
lysosomal FC accumulation alone has the potential to inhibit lysosome function by 
inhibiting the ability of lysosomes to maintain the correct pH. Initial accumulation of FC 
is an event common to all three physiological loading vehicles as well as with ac-LDL in 
the presence of progesterone and is thus a strong candidate for the common mediator of 
the subsequent lysosomal CE accumulation.  
Not all vesicles in macrophages are lysosomes, although in active macrophages a 
significant proportion of intracellular vesicles are lysosomes (Ross and Auger, 2002).  
Thus, not all of the vesicles with pH above 4.8 are inactive lysosomes.  Additionally, the 
vesicles that are observed with a pH above 4.8 would most likely be in untreated cells as 
well.  These vesicles could account for the initial 15-20% reduction observed in active 
lysosomes. There is no direct way to determine the pH only of lysosomes, since it is not 
possible to stain cells for both lysosomal marker proteins, such as LAMP-1, and pH 
sensitive dyes concurrently. Furthermore, treatment of the cells with fluorescently labeled 
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dextrans did not completely localize with lipid filled lysosomes and could thus give an 
inaccurate lysosomal pH measurement (data not shown).  However, in the current studies 
using a pH dependent fluorescent dye we have shown that a majority of macrophage 
vesicles were lysosomes/late endosomes and that treatment with agg-LDL or DISP 
increased the percentage of total vesicles in the cell that represent lysosomes. In contrast, 
with cholesterol loading, the percentage of vesicles with pH below 4.8 declined 
dramatically. In addition, we have shown previously that the majority of the FC 
accumulation in macrophages incubated with agg-LDL or DISP accumulates in LAMP-1-
positive vesicles (Griffin et al., 2005). Taken together, these data indicate that the 
majority of vesicles with pH greater than 4.8 in treated cells are inactive lysosomes/late 
endosomes and these inactive lysosomes have significant FC accumulation.   
 
Lysosomal free cholesterol results in inactive lysosomes 
 The ability of progesterone to inhibit unesterified cholesterol traffic out of 
lysosomes is a major and well characterized effect of progesterone treatment (Butler et 
al., 1992; Mazzone et al., 1995). Although the largest effect of progesterone on 
macrophages is inhibition of cholesterol movement (Butler et al., 1992), progesterone has 
other effects on macrophages, including stimulating production of growth factors and 
increases in synthesis of cholesterol and sterol precursors (Metherall et al., 1996; Maruo 
et al., 2003). However, these additional effects would also be present in cells treated with 
progesterone alone and, thus, cannot be the explanation for the inhibition of lysosomal 
acidification. Moreover, treatment of cells with ac-LDL in the presence of 2 µg / ml 
U1866A (3ß-[2-(diethylamino)ethoxy]androst-5-en-17-one), which also modulates 
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trafficking of cholesterol out of lysosomes, equally inhibits lysosomal CE hydrolysis 
(unpublished observation).  Furthermore, treatment of cells with U1866A, which is an 
amine containing compound, has the possibility to affect lysosomal pH.  Thus U1866A 
could inhibit lysosomal hydrolysis through this mechanism and the role cholesterol plays 
in lysosomal pH regulation would be more difficult to determine.   
A decline in lysosome or cell viability is also not the explanation for the 
progesterone effect, since ac-LDL plus progesterone treatment did not change cell 
viability.  Additionally, the lysosomes of cells treated for 24 hours could regain activity 
after the progesterone block was removed. Thus, we conclude that the lysosomal FC 
accumulation produced by our modified particles, or by progesterone treatment in the 
presence of ac-LDL, is the most likely candidate for the decreased ability of lysosome’s 
to maintain a pH level conducive to lysosomal lipase activity.   
Of particular interest is our observation that short-term cholesterol accumulation 
was completely reversible but that longer-term incubation, leading to higher lysosomal 
FC levels, was less reversible. One explanation is that those lysosomes able to re-acidify 
represent a younger population of lysosomes with less unesterified cholesterol.  However, 
once a high FC level is reached, the lysosome cannot recover. Further experimentation 
will be required to confirm this hypothesis.  If lysosomes of macrophages in the 
atherosclerotic lesions were equally resistant to lowering of foam cell cholesterol efflux, 
they would be expected to maintain their lysosomal-engorged phenotype and be resistant 
to regression diets. Consistent with this, in a study of pigeon atherosclerosis, it was found 
that the cholesterol in foam cell lysosomes was resistant to regression (Jerome and Lewis, 
1990). 
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Our results are in contrast to a report indicating that fibroblasts from patients with 
Neimann-Pick Type C (NPC) disease do not have an elevated lysosomal pH (Bach et al., 
1999). Mutations in the NPC-1 protein cause cholesterol to accumulate within lysosomes. 
It is not clear why the pH of these lysosomes remains acidic, but one possible explanation 
is that the FC levels in these cells never reach sufficient concentration to inhibit proton 
pumping. In our studies, we see no decrease in active lysosomes after 24 hours despite 
clear evidence that FC is accumulating in lysosomes. It appears that the lysosomes begin 
to fail at maintaining an active pH only after sufficient FC accumulates. It would be 
interesting to determine if challenging NPC-1 mutant cells with lipoprotein to further 
increase lysosomal cholesterol levels resulted in an increase in lysosomal pH. Similarly, 
it is not clear why the ac-LDL plus progesterone treatment produced a more rapid 
increase in lysosome pH (1 day compared to ≥ 2 days for particles) except that 
progesterone treatment, by severely inhibiting lysosomal loss of FC, would be expected 
to increase lysosomal FC very rapidly.  These data suggest that there may be a threshold 
level of FC that must be reached prior to lysosomal inactivation.  Isolating cholesterol 
enriched lysosomes to determine if there is a correlation directly with FC and lysosomal 
inhibition could yield significant data on the mechanism of lysosomal inhibition.  
Furthermore, determining if there could be a change in the molar ratios of cholesterol to 
phospholipid and the type of phospholipid present would be important because there is 
ample evidence in other systems that these factors play a critical role in the activation of 
the v-ATPase (Xie et al., 1986; D'Souza et al., 1987; Yeagle, 1991; Mattsson et al., 
1994). 
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CHAPTER III 
 
 
Lysosomal sterol accumulation does not affect the levels of the H-
subunit of the vacuolar-ATPase but does inhibit the activation of the 
vacuolar-ATPase 
 
Introduction 
Lysosomal FC accumulation precedes lysosome inactivation suggesting FC 
accumulation may mediate the increase in lysosome pH.  Also, inhibition of ac-LDL-
derived FC egression from lysosomes is accompanied by lysosome inactivation (Cox et 
al., 2007). To address potential mechanisms by which FC might influence lysosome pH, 
we investigated the effect of FC on the lysosomal v-ATPases. V-ATPases are integral 
membrane pumps which utilize ATP hydrolysis to pump protons into the lysosome lumen 
and thus, maintain an acidic pH. One possibility for the loss of lysosomal activity could 
be that there is a decrease in the levels of the v-ATPase. Since the v-ATPase is a multi-
protein complex, we monitored the H-subunit of the complex because it is required for 
the formation of an active v-ATPase complex (Lu et al., 2002; Wilkens et al., 2004).  A 
second possibility for the loss of lysosomal activity is that there is a failure of the v-
ATPase to pump protons into the lysosomal lumen.  To explore this possibility, we 
measured quenching of acridine orange fluorescence in the presence of isolated 
lysosomes when the lysosomal v-ATPases were stimulated with ATP (D'Souza et al., 
1987; Crider and Xie, 2003). 
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Experimental procedures 
Lysosomal isolation and modification 
THP-1 macrophages were incubated with MyOne magnetic beads (Invitrogen, 
Carlsbad, CA) for 72 hours at a concentration of 0.03 mg / ml.  After allowing 
internalization of the beads for 72 hours, the cells were rinsed and media containing 1% 
FBS was added for an additional 72 hours. This allowed beads on the cellular surface or 
in the endosomal compartment to be incorporated into lysosomes.  The cells were then 
rinsed 2 times in cold STE buffer (0.25 M sucrose, 0.01 M Tris-HCl, 1 mM EDTA, 0.1% 
ethanol) and scraped into 1 ml / dish of STE buffer containing protease inhibitors (Sigma, 
St Louis, MO).  A total of six 100 mm dishes were used for each condition.  The cell 
suspension was then placed in a cell disruption chamber (Kontes) and disrupted using 3 
passes of 20 minutes each at 150 psi.  This method consistently resulted in disruption of 
greater than 95% of cells.  Western blotting for LAMP-1 indicated this method provided 
more consistent disruption of the cells compared to a Dounce tissue grinder.   
We separated a purified population of lysosomes from the homogenate by placing 
the suspension in a magnetic field for 15 minutes. At the end of this period, the pellet 
containing bead loaded lysosomes was resuspended in buffer.   To determine the effect of 
membrane FC levels on v-ATPase activity, the FC levels in isolated lysosome 
membranes were increased or decreased.  To enrich lysosomal membranes with FC, 
isolated lysosomes were incubated with varied concentrations of methyl-β-cyclodextrins 
(MβCD) which were enriched with FC (Klein et al., 1995).  MβCDs have been used 
extensively as a means of modulating membrane cholesterol levels (Yancey et al., 1996; 
Christian et al., 1997; Goodwin et al., 2005). After a 15 minute incubation, the lysosomes 
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were reisolated and washed in buffer to remove the MβCD s.  Aliquots were taken for 
cholesterol (via GC) and protein (via Lowry) analysis to confirm the increase in 
lysosomal FC.   As controls, lysosomes were incubated with α-cyclodextrin (CD), which 
does not mobilize FC and then subjected to the activation protocol.  To test if the 
inhibition of the v-ATPase through increasing membrane FC was reversible, FC poor 
MβCD was utilized to return the FC enriched lysosomes back to an untreated lysosomal 
FC level.  For most experiments, lysosomes were incubated twice, for 15 minutes each 
time, with the FC poor MβCD.  This insured that sufficient FC was removed from the 
membrane to return the cholesterol level to a level similar to untreated lysosomes.  
 
Lysosomal activation 
Lysosomal activation was carried out using a modification of a procedure 
described previously (Crider and Xie, 2003).  Proton pumping was measured as the 
quenching of acridine orange fluorescence when hydrogen ions are pumped into the 
lysosomal lumen.  Briefly, isolated lysosomes were resuspended in lysosomal 
reconstitution buffer (0.25 M sucrose, 0.1 M HEPES, 1 mM EDTA, 150 mM KCl) to 
generate high K+ levels inside the lysosome and produce a membrane potential during 
stimulation of the v-ATPase with ATP. Prior to activation, the lysosomes were 
resuspended in lysosomal reconstitution buffer containing 6.7 µM acridine orange, to 
allow the dye to equilibrate between the outside of the lysosome and the lysosomal 
lumen.  After this incubation, 5-10 µg of isolated lysosomes were diluted in a cuvette 
containing 1.4 ml activation buffer (0.25 M sucrose, 0.1 M HEPES, 1 mM EDTA, 150 
mM NaCl) containing 6.7 µM acridine orange.  A steady baseline, determined as the ratio 
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of sample to reference fluorescence intensity, was obtained and then the v-ATPases were 
primed with MgCl2.  As soon as the baseline was reestablished (approximately 1 minute), 
the v-ATPases were activated by the addition of ATP (1.4 µM final concentration) and 
valinomycin (to promote formation of a membrane potential).   V-ATPase driven 
pumping of hydrogen ions into the lysosome lumen is determined as a quenching of 
acridine orange fluorescence when excited at 495 nm and recorded at 530 nm using an 
SLM Aminco 8100 dual wavelength spectrophotometer.   As acridine orange is 
protonated it aggregates, which changes its fluorescence.  As controls, beads not within 
lysosomes were subjected to activation.  As an additional control, lysosomes were 
activated with ATP in the absence of valinomycin.  
 
Western blotting 
After isolation and also after cholesterol modulation using the magnetic bead 
isolation procedure described above, an aliquot was removed and the proteins were 
precipitated using a trichloroacetic acid (10% of final volume), delipidated using acetone, 
re-solubilized using 10% SDS in water with sonication.  The re-solubilized proteins were 
then loaded on a 4-12% gradient Bis-Tris SDS-PAGE gel (Invitrogen, Carlsbad, CA), run 
for 15 min at 100 V and 90 min at 120 V, and transferred to nitrocellulose for 90 min at 
25 V.  Blots were stained using a primary antibody v-ATPase H-subunit (1:1000) (Santa 
Cruz) or LAMP-1 (1:50000) (BD Bioscience, San Jose, CA).  Secondary antibodies 
conjugated to HRP were obtained from Promega (Madison, WI) and detected using ECL 
(PerkinElmer Life Sciences, Boston, MA) and Kodak Biomax film.   
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Results 
One potential mechanism for the inhibition of lysosomal activity would be 
changes in the levels of the v-ATPase.  The v-ATPase is a multi-protein complex with a 
transmembrane domain, v0, and a cytosolic domain, v1.  The H-subunit of the v1 domain, 
a protein in the stalk region, is required for activation of the complex (Lu et al., 2002; 
Crider and Xie, 2003; Wilkens et al., 2004).  Therefore, changes in the level of the H-
subunit would suggest changes in the lysosomal activity.  We observed no difference in 
the levels of the H-subunit between our controls and any of our lipid treatments (agg-
LDL, ac-LDL, ac-LDL with progesterone, or ox-LDL)(Figure 11) throughout the time 
course of the experiment (1, 3, or 7 days). This suggests that inactivation of lysosomes is 
not a function of reduction in v-ATPase levels. 
Another potential mechanism for the inhibition of lysosomal activity is that FC 
accumulation in the lysosome membrane is directly affecting the activation of the v-
ATPase.  Therefore, v-ATPase activity in normal and cholesterol-enriched lysosomes 
was assayed by monitoring acridine orange quenching.  In a representative experiment, 
cholesterol-normal lysosomes (1.50 µg cholesterol/ mg lysosome protein) exhibited a 
rapid quenching of the acridine orange, showing that the v-ATPases in non-cholesterol 
enriched lysosomes were pumping protons into the lysosomal lumen (Figure 12).  When 
the lysosomal membrane cholesterol was increased 46% (2.19 µg cholesterol / mg 
lysosome protein) by incubating the isolated lysosomes with FC-containing MβCD there 
was a reduction in the ability of lysosome membranes to quench acridine orange in the 
lysosome lumen. A 130% increase in cholesterol concentration (3.46 µg cholesterol / mg 
lysosome protein) over that seen in controls, almost completely in   
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Figure 11: Western blot of the H-subunit (H-Sub) of the v-ATPase in cells loaded with 
agg-LDL or ox-LDL showed no difference over time in the H-subunit concentration 
compared with untreated cells. Likewise, ac-LDL loading or ac-LDL loading in the 
presence of progesterone did not alter H-subunit levels. Ten micrograms of protein was 
loaded in each lane. Incubation conditions were as described in methods. Cells loaded 
with inert beads acted as a control for lysosome stimulation. Some macrophages 
incubated with ac-LDL and progesterone for 3 days were allowed a further 3 day washout 
before analysis (D3+D3W). D1= day 1, D3= day 3, D6= day 6.  β-actin was used as a 
load control.  
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inhibited the activity of the v-ATPases.  Each cholesterol augmentation experiment was 
repeated at least 3 times with similar results each time. 
Just as FC-enriched CD can transfer cholesterol to membranes, MβCD without 
cholesterol can remove cholesterol from membranes (Yancey et al., 1996). When we 
increased lysosomal membrane FC in isolated lysosomes to inhibitory levels (3.5 fold 
increase) using FC-containing MβCD and then reduced it by sequential incubations for 
15 minutes with 1 mg / ml FC-poor MβCD to only a 1.5 fold increase (3.21 µg 
cholesterol / mg lysosome protein) over control levels, we regained some v-ATPase 
activity. The level of activity seen with this final 1.5 fold cholesterol increase over 
control levels was similar to that seen in lysosomes in which we obtained a modest 1.3 
fold increase in lysosome membrane cholesterol (Figure 12) through brief incubation 
with FC-enriched MβCD. 
As a control for MβCD treatment, isolated lysosomes were treated with α-
cyclodextrin, which does not transfer cholesterol, but has been shown to interact with the 
membrane similar to MβCD (Shvartsman et al., 2006). This did not inhibit quenching of 
acridine orange fluorescence (Figure 13).  Further controls included incubating isolated 
lysosomes with ATP in the absence of valinomycin, so no membrane potential would be 
generated,  and testing whether magnetic beads alone (without v-ATPase containing 
membranes) in the presence of activation buffer resulted in acridine orange quenching 
(Figure 13).  These controls did not produce a quenching of acridine orange fluorescence, 
confirming that inhibition of quenching was related to inhibition of v-ATPase activity by 
cholesterol.   
 
 62
  
 
 
 
Figure 12:  Quenching of acridine orange fluorescence in isolated lysosomes before or 
after cholesterol enrichment. Once stimulated by the addition of ATP and valinomycin 
(time 0), untreated lysosomes (squares) exhibit a rapid quenching of the acridine orange 
fluorescence, as indicated by the decrease in the relative fluorescence intensity.  Acridine 
orange quenching is the result of activation of the v-ATPase and pumping of hydrogen 
ions into the lysosomal lumen.  Lysosomes with a 46% increase in membrane 
unesterified cholesterol (circle) exhibit a reduction in overall quenching of the acridine 
orange.  Larger increases in cholesterol levels to greater than 1.3 fold, (inverted triangle) 
almost complete inhibited v-ATPase activity.  
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Figure 13:  Isolated lysosome membranes and a membrane potential are required to 
quench acridine orange.  Isolated lysosomes were incubated in the acridine orange 
activation buffer as described in the methods section and subjected to activation, except 
the valinomycin was omitted from the procedure (ATP only). Under these conditions, no 
quenching of the acridine orange was observed.  To determine if the magnetic beads used 
for lysosome isolation have an effect on acridine orange quenching, pure magnetic beads 
were subjected to the complete activation protocol (Beads only) and no quenching of the 
acridine orange was observed.  These controls demonstrate that isolated lysosomes and a 
membrane potential are essential for the activation of the v-ATPase and the quenching of 
acridine orange.  To determine if cyclodextrins alone have an effect on the activation of 
isolated lysosomes, isolated lysosomes were incubated with α-cyclodextrin (1.0 mg / ml). 
Unlike β-cyclodextrins, empty α-cycodextrins do not mobilize cholesterol from 
membranes.  After treatment, isolated lysosomes were washed, and then subjected to the 
complete activation protocol (α-CD).  The α-CD-treated lysosomes exhibited a rapid 
quenching of the acridine orange fluorescence indicating activation of the v-ATPase.  
This control demonstrates that cyclodextrins alone do not affect activation of the v-
ATPases; suggesting that it is the manipulation of lysosome membrane FC by MβCD that 
is responsible for the changes in lysosome v-ATPase activity observed in our studies. 
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Discussion 
 General discussion 
The v-ATPase is directly responsible for the acidification of the lysosome; hence, 
affecting the protein levels or activities of the v-ATPase could result in improper 
acidification of the lysosome.  We found that the inhibition of lysosomal acidification 
was not due to the protein levels of the v-ATPase in the cell.  The activity of the v-
ATPase was then examined, since it would be the other major potential mechanism for 
the decrease in acidification.  Correspondingly, membrane properties, in particular the 
levels of cholesterol, have been demonstrated to relate directly to the activity of the v-
ATPase (D'Souza et al., 1987; Crider and Xie, 2003).  We have shown with the preceding 
data that modulation of the membrane cholesterol levels in isolated lysosomes alters the 
activity of the v-ATPase.  Moreover, increasing the membrane cholesterol inhibits 
protons from being pumped into the lysosomal lumen.  Inhibition of proton translocation 
is a possible mechanism for the decrease in the lysosomal activity observed in 
macrophage foam cells.  This corresponds with other data indicating a general inhibition 
of lysosomal function and data suggesting that inhibiting FC egression out of the 
lysosome resulted in inactivation of the lysosome (Chapter II). 
 
Increasing membrane free cholesterol inhibits v-ATPase activation 
 Our data demonstrate that increased lysosomal membrane FC inhibits v-
ATPase activation.  The mechanism is unknown, but it is possible that the FC 
accumulating in lysosomes partitions into the membrane and inhibits the v-ATPases. The 
acidic pH of lysosomes is maintained by these v-ATPases.  The v-ATPases are 
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multimeric proteins that pump H+-ions into the lysosome using hydrolysis of ATP as the 
energy source. Additionally, the efficiency of the v-ATPase can be affected in some cell 
types by membrane cholesterol concentration (Ambudkar and Maloney, 1986; D'Souza et 
al., 1987; Crider and Xie, 2003).  Here we show for the first time that, in human 
macrophages, lysosome inactivation is not due to a decrease in levels of the v-ATPase.  
Furthermore, augmentation of lysosomal membrane FC concentration can inhibit 
lysosomal v-ATPases and produce an inactivation of lysosomes. Taken together, our 
observations suggest a direct effect of FC on lysosome acidification. We are currently 
pursuing studies to identify more details of how this inhibition occurs.   
  An alternate explanation for some of our data would be that increased lysosomal 
FC could increase leakiness of the lysosomal membrane. If protons were not retained 
within the lysosomes, pH would increase. However, several lines of evidence argue 
against this explanation. First, cholesterol increases order in membranes and makes them 
less permeable and has been shown to decrease lysosome leakiness (Wan et al., 2002). 
Moreover, increased lysosome leakiness produced by a number of different factors, 
including some oxidized sterols, is generally associated with apoptosis (Li et al., 2000; 
Yuan et al., 2000).  We do not see increased apoptosis in our cells. Finally, the time 
course of our studies could not account for the decrease in activity because the acridine 
orange quenching is rapid and is the result of the protonation of the acridine orange.  If 
the v-ATPases were actively transporting the protons into the lysosomal lumen it is 
unlikely that they could leak out of the lysosomes prior to protonating the acridine orange 
which retains the protons within the lysosome. Thus, leakiness would not appear to 
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explain our results. However, we cannot rule out increased leakiness as an exacerbating 
factor.  
 Taken together, the simplest explanation for our observations is that alteration in 
lysosomal pH accounts for the lack of CE hydrolysis we have seen in other studies and 
the lack of apo B degradation reported here. Although different lysosomal enzymes have 
different pH maxima, most require an acidic environment. The LAL responsible for CE 
hydrolysis has a very narrow pH range with almost no activity above pH 4.5 (Sando and 
Rosenbaum, 1985a).  Cholesterol accumulation from mildly ox-LDL, agg-LDL, and 
DISP increased the lysosomal pH to a point well above that at which LAL would be 
active. Some lysosomal proteases have a wider pH range with some activity above pH 4.8 
which might explain why some apo B is only degraded to small fragments (Conner, 
1998).   
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CHAPTER IV 
 
New findings and future directions 
 
Introduction 
 The preceding data show that lysosomal membrane cholesterol inhibits the 
activity of the v-ATPase, but the mechanism for inhibition is still unknown.  
Furthermore, the preceding studies were conducted utilizing a lysosomal isolation with an 
artificial FC enrichment process and not lysosomes that have been lipid loaded 
intracellularly.  Therefore, it still needs to be determined whether lysosomal inhibition in 
lipid-engorged macrophages occurs through the same mechanism as that in isolated 
lysosomes.  For these reasons, we have initiated studies to elucidate the mechanism of v-
ATPase inhibition and to determine if a similar inhibition of the v-ATPase is occurring in 
lysosomes in lipid engorged cells.  The first section of this chapter will focus on our new 
studies where we analyze the mechanism of v-ATPase inhibition, the coupling of the two 
v-ATPase domains, and ATP hydrolysis after in vitro cholesterol manipulation of isolated 
lysosomes.  We use similar techniques to analyze v-ATPase activation in lysosomes 
isolated from lipid-loaded cells.  These data will aid in elucidating the mechanisms of 
lysosomal inhibition in lipid-engorged macrophage foam cells.  The second portion of the 
chapter will focus on the future directions of these studies.  
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Experimental Procedures 
Inorganic phosphate production 
ATP hydrolysis was assayed by measuring the production of inorganic phosphate 
(PiBlue, San Francisco Scientific, San Francisco, CA).  Standards containing known 
amounts of phosphate were made using serial dilution of the concentrated solution 
provided in the kit and ranged from 200-2000 pmol phosphate.  For the experimental 
conditions 50 µl of activation buffer containing MgCl2 was placed in the wells of a 96-
well plate.  To this 2-5 µg of lysosomal protein was placed in the well for each condition.  
To activate the lysosomes 1.1 µl of an ATP-valinomycin (ATP-v) mixture was added 
(final ATP concentration 0.01 µM).  For termination of the reaction, 100 µl of the Pi-
Blue reagent was added.  Control, for the presence of inorganic phosphate in the assay, 
are as follows:  activation buffer only, lysosomes without ATP-v, ATP-v without 
lysosomes, and lysosomes kept in isolation buffer (no potassium for membrane potential) 
with ATP-v.  A minimum of 4 wells per condition were measured and averaged per 
experiment. 
 
Sucrose gradient lysosomal isolation 
 Macrophages were either loaded with agg-LDL (100 µg / ml) or kept in 1 % FBS 
serum for six days, with changes after 3 days.  After six days, the macrophages were 
scraped into 0.5 ml STE buffer containing protease inhibitors.  The resulting cell 
suspension was subjected to nitrogen cavitation as described in the previous chapter.  
Once the cells were disrupted, the cell lysates were subjected to centrifugation at 500 x g 
for 10 minutes, to separate whole cells, nuclei, and cell debris.  The supernatant was 
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removed.  The pellet was then resuspended in 1-2 ml of STE buffer and centrifuged a 
second time.  The resulting supernatant was added to the first.  The density of the 
supernatant was increase to 1.15 g/ml through the addition of 0.314 g of sucrose per ml of 
supernatant.   
 For the isolation of differing density lysosomes, the supernatant was then 
subjected to a sucrose gradient ultracentrifugation.  The densities of the sucrose layers 
were as follows: 1.28 g/ml, 1.15 g/ml, 1.10 g/ml, 1.01 g/ml, and 1.00 g/ml.  The volume 
of each layer was adjusted according to the volume of the 1.15 g/ml supernatant layer, 
but was generally as follows: 1 ml, 5.0 ml, 3.5 ml, 3.0 ml, 0.5 ml, respectively.  The 
centrifugation was conducted using a SW-40 rotor in a Beckman ultracentrifuge.  The 
lysosomes were centrifuged at 19400 rpm (48000 x g) for 4 hours.  The resulting 
lysosomal layers were isolated using an ultracentrifuge tube slicer.  Aliquots of each layer 
were taken for GC and protein analysis.  The remaining fraction was subjected to either 
the v-ATPase activation assay, as described previously, or to negative stain TEM.  
Separate experiments were conducted for Western blot analysis to verify the purity of the 
fractions for LAMP-1 and H-subunit analysis, as described previously.   
 
Results 
Potential uncoupling of v-ATPase domains as a result of membrane 
thickening 
 
The v-ATPase is a large multimeric protein complex consisting of two domains 
that function together to transfer protons into the lysosomal lumen.   Altered membrane 
properties could affect the assembly and the activity of the complex, i.e. ATP hydrolysis 
occurs, but protons are not pumped into the lysosomal lumen.  This is feasible because it 
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has been suggested that the association of the two domains is reversible (Kane, 2000).  
Thus, if the domains were to separate, changes in the membrane might inhibit the re-
association of the domains.   However, we did not observe the loss of the H-subunit as we 
increased the cholesterol levels in isolated lysosomes, suggesting that the two subunits 
may remain intact (Figure 14).  These data suggest that the two v-ATPase domains do not 
uncouple. 
To definitively prove the two domains do not uncouple we measured the 
production of inorganic phosphate.  Our experiments indicate that when the cholesterol 
level increased or decreased, there is a reduction in the production of inorganic phosphate 
(Figure 15).  These data confirm that the ATPase activity of the v-ATPase complex is 
sensitive to perturbations in the membrane cholesterol level.  The inhibition of the 
complex leads to inhibition of proton translocation and the lysosomes therefore become 
neutralized.  However, the fact that increasing the cholesterol concentration of isolated 
lysosomes does not result in the loss of the H-subunit (Figure 14) provides evidence that 
cholesterol concentration does not produce a functional separation of the two domains.  
Additionally, even though we do see a reduction in the production of inorganic phosphate 
there is still some production, suggesting that hydrolysis is not completely inhibited.  
Therefore, it is possible that we are observing a partial uncoupling of the two domains, 
which might be similar to that observed using Ca2+ (Crider and Xie, 2003), but this 
potential mechanism has yet to be tested.  Other membrane properties, such as leakiness, 
could also play a role in lysosomal inhibition (Haines, 2001; Wan et al., 2002).   
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Figure 14:  H-subunit protein level is not reduced upon cholesterol increase.  
Lysosomes were isolated using magnetic beads and then subjected to cholesterol increase 
using FC-enriched CD between 1.0 mg/ml and 5.0 mg/ml, which corresponded with an 
increase in cholesterol between 2-10 times control levels.  The lysosomal proteins were 
then isolated and run on a 4-12% SDS-PAGE gel and blotted for either H-subunit (top 
band) or LAMP-1 (lower band).  The blot shows that even after significant cholesterol 
increase Lane 4 there are similar amounts of H-Subunit present in the isolated lysosomes.  
These data show that a physical uncoupling of the two domains of the v-ATPase is not 
responsible for the reduction in v-ATPase activity.  
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Figure 15:  The production of inorganic phosphate was measured as the stimulation of 
ATP hydrolysis in isolated lysosomes and isolated lysosomes after membrane cholesterol 
modifications.  Lysosomes were stimulated as done with the acridine orange quenching.  
In normal or untreated lysosomes there is approximately 800 pmol phosphate produced 
after stimulation with ATP (NL+ATP).  However, after a three-fold increase (3.36 ug) in 
cholesterol phosphate production was reduced by approximately 200 pmol (+1+ATP).  
The lysosomes that had been subject to cholesterol increase were then subjected to 
cholesterol removal using cholesterol poor cyclodextrin and then analyzed for phosphate 
production.  The cholesterol levels in these lysosomes were 60% above normal lysosome 
levels (1.77 ug) and phosphate production was returned to that of the normal lysosomes.  
Graph represents mean and standard deviation, means are not significantly different. 
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Unanswered Questions 
 The preceding data indicate that the two v-ATPase domains do not uncouple 
when membrane FC levels are increased.  However, ATP is still hydrolyzed, albeit to a 
lesser extent than untreated lysosomes.  Therefore, the exact mechanism of v-ATPase 
inhibition has yet to be determined.  This raises two questions: 1. Does membrane 
organization play a role in v-ATPase inhibition? 2. Is there a second transporter involved 
in the activation of the v-ATPase (possibly by establishing or maintaining a membrane 
potential)?  Cholesterol is known to have multiple effects on membrane organization and 
properties (Yeagle, 1991); thus, determining how membrane organization changes as 
cholesterol levels increase will be critical in defining the role of the membrane in v-
ATPase activation.  The data also indicate that a membrane potential is required for v-
ATPase activation, which suggests v-ATPase activation is linked to a second ion 
transporter.  Identifying this transporter and determining whether cholesterol has an effect 
on its activity would be important in defining the mechanism of v-ATPase activation.   
 
Lysosomes from lipid loaded cells fail to activate 
Our lab has been able to isolate three to four distinct populations of lysosomes in 
cells that have been lipid-loaded in culture.  The different populations appear to reflect 
different degrees of sterol accumulation. These populations correspond to normal or 
heavy lysosomes, one-two populations of slightly lipid enriched lysosomes, and a very 
lipid enriched population of lysosomes.  We have analyzed the heavy or normal 
lysosomal fractions from untreated control and agg-LDL treated macrophages for v-
ATPase activity through acridine orange quenching.  Notably, we find that in cells loaded 
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with agg-LDL, even lysosomes that are isolated at the same density as normal lysosomes 
in control cells, there is a failure of v-ATPase activation (Figure 16).  Additionally, even 
though they float at a similar density to fully active lysosomes, these lysosomes have 
almost three times the cholesterol concentration of lysosomes from cholesterol normal 
cells.  These data suggest that v-ATPase activity within heavily loaded foam cells is 
inhibited.   Supporting this finding are data showing that the majority of lysosomes 
within lipid loaded cells exhibit an elevated lysosomal pH (Chapter II).   
To characterize the isolated lysosomes more thoroughly, the various lysosome 
subfractions were subjected to negative stain TEM and examined for size distribution and 
shape.  The lysosomes from the untreated macrophages were primarily composed of 
small unilaminar vesicles that were between 175-225 nm in diameter (Figure 17A).  
However, the “normal” density lysosomes isolated from the macrophages treated with 
agg-LDL resulted in large vesicles, between 1-2 microns in diameter, which appeared to 
have large quantities of lipid stored internally (Figure 17B).  Our analytical data indicate 
that these lysosomes have three times the cholesterol levels observed in the lysosomes 
from the untreated cells, and thus the ATPases would be inhibited.   
 
Unanswered Questions 
The preceding indicate that even normal density lysosomes from agg-LDL treated 
macrophages are inhibited.  Therefore, material is continually being delivered to these 
lysosomes (Yancey et al., 2002), but the lysosomes are incapable of degrading the 
material.   This suggests that v-ATPase inhibition, similar to that observed using the 
isolated lysosomal system, is occurring in lysosomes from lipid engorged macrophages.   
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Figure 16:  Isolated lysosomes from agg-LDL treated macrophages fail to activate 
the v-ATPase.  Lysosomes were isolated using a sucrose density gradient from either 
control untreated macrophages or macrophages treated with agg-LDL in culture for six 
days.  The normal or heaviest fraction of lysosomes was subjected to the activation assay 
using acridine orange quenching as readout.  The control lysosomes had 1.11 µg 
cholesterol and exhibited rapid quenching of the acridine orange, similar to that observed 
in bead isolated lysosomes.  However, the lysosomes from macrophages treated with agg-
LDL had 2.88 µg cholesterol and did not quench the acridine orange.   
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Figure 17:  Lysosomes from agg-LDL treated macrophages are much larger than similar 
density lysosomes from untreated control macrophages and appear to have internalized 
lipid.   Lysosomes, isolated using a sucrose density gradient, were subjected to negative 
stained transmission electron microscopy.  Lysosomes from control cells (A) were 
unilaminar vesicles that were on average less than .2 microns in diameter.  However, 
lysosomes of similar density isolated from macrophages treated with agg-LDL  (B) for 
six days appear to have lipid in the lysosomal lumen, which corresponds to the increased 
cholesterol level.  The lysosomes were also much larger, averaging 1-2 microns in 
diameter.  Magnification 31000X. 
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However, several questions remain:  1. Is there a threshold level of cholesterol, which, 
once reached, inhibits the v-ATPase?  2. Does the increase in lysosomal volume affect 
lysosomal acidification?  3. Are newly synthesized v-ATPases trafficked properly to the 
lysosome during foam cell formation?   As foam cells develop, the lysosomes experience 
a significant increase in cholesterol level and size; therefore, it will be interesting to 
conduct a timecourse of the lysosomal isolation and determine the activity, size and 
cholesterol levels and correlate this with the whole cell data.  The data generated will 
allow determination of whether cholesterol threshold or increased lysosomal volume is 
responsible for the lysosome inactivation.  Additionally, determining how newly 
synthesized v-ATPases are trafficked will be important.  If there is no increase in the 
concentration of v-ATPases in a given lysosome, are the starting levels of v-ATPases 
sufficient to maintain the acidic environment of the lysosome?  How these questions 
could be analyzed is discussed in more detail below.   
 
Future Directions 
Potential role of cholesterol induced membrane organization 
 Cholesterol is known to induce increased order of the phospholipid membrane as 
its concentration increases (Bretscher and Munro, 1993).  This increase in order 
corresponds with an increase in the rigidity of the membrane.  Both of these factors are 
known to induce changes in movement and function of transmembrane proteins.  The 
group of Tabas has recently shown, using electron spin resonance (ESR), that increases in 
the membrane cholesterol inhibits the activity of a Ca2+-ATPase in the sacroplasmic 
reticulum (Li et al., 2004).  Using ESR, they show that the inhibition is directly related to 
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the increase in membrane order (Li et al., 2004).  ESR studies have also shown that 
several inhibitors of v-ATPase also alter the membrane order (Dixon et al., 2004).  Thus, 
it will be important to determine if cholesterol induces changes in membrane order and if 
these are directly associated with v-ATPase activity.  While the Ca2+-ATPase is different 
from the v-ATPase it would be interesting to utilize techniques worked out for Ca2+-
ATPase to examine changes in membrane order in isolated lysosomes when the 
membrane cholesterol content has been modified in ways that have an effect on v-
ATPase activity.  These studies could also be used to determine the membrane properties 
of lysosomes isolated from cells that have been cholesterol enriched in culture.   
There are several experimental areas where examining membrane order could be 
utilized.  Using the magnetic bead lysosomal isolation procedure, the effect of varied 
cholesterol concentration on membrane order could be examined.  This would allow for 
the determination of whether the human v-ATPase also exhibits a bell shaped curve of 
activity, as was found for the bovine v-ATPase (Crider and Xie, 2003).  Understanding 
how cholesterol levels affect v-ATPase activity would be important because it would 
demonstrate if there is a narrow concentration of membrane cholesterol in which the v-
ATPase is active.   Furthermore, determining the effect of cholesterol concentration on v-
ATPase activity would aid in determining how stringently v-ATPase activity is linked to 
membrane fluidity.  This would also allow us to determine how well the inhibition of 
activity we have reported here is linked to the membrane properties. If the v-ATPase is 
inhibited outside of the physiological range would be important because the sodium-
potassium ATPase has been demonstrated to have little activity outside of the 
physiological cholesterol concentration range (Yeagle et al., 1988).  Inhibition of the 
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sodium-potassium ATPase has been shown to have detrimental effect on the cell and 
kidney as a whole.  It could be argued that if the v-ATPase inhibition was occurring in 
the lysosome of the macrophage, the cell biology could be significantly affected.   
 
 Potential role for the v-ATPase being connected to a second ion channel 
 There is the possibility that a membrane potential is required for complete 
activation of the v-ATPase; therefore, it would be interesting to search for other ion 
pumps that may localize to the lysosome and determine if these affect lysosomal 
acidification.  A second ion transporter may be necessary because a membrane potential 
seems to be required for v-ATPase activation in systems most closely related to the 
human (Crider and Xie, 2003).   Some have reported that while a membrane potential 
may be needed, an electro-chemical gradient may not be required in all systems 
(Ambudkar and Maloney, 1986; D'Souza et al., 1987).  However, creating a gradient did 
enhance the acidification of the lysosomal lumen in one study (D'Souza et al., 1987).  
Furthermore, in the studies presented here, an electro-chemical gradient had to be 
initiated, using valinomycin, prior to stimulating the v-ATPase with ATP.  Therefore, 
analyzing the proteome of different populations of lysosomes and determining which ion 
transporters are in or are lost in all lysosomal populations could provide a link between 
additional lysosomal ion transporters.  These data could be linked to inactive lysosomes 
and could yield substantial data to the lysosomal hydrolytic and v-ATPase fields.  
There are two possibilities for the inactivation of the v-ATPase if it is linked to a 
second transporter.  The first would be that the increased lysosome surface area that 
accompanies the lysosomal sterol accumulation causes the additional transporter to be 
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trafficked improperly or to be present in insufficient quantity. The second possibility is 
that the second transporter is even more sensitive to cholesterol concentration than the v-
ATPase.  Therefore, if there are certain ionic pumps that traffic along with the v-ATPase, 
it would be interesting to examine how they are affected by the increase in the membrane 
cholesterol levels.  To do this a proteomic approach could be utilized.  In our lab we can 
consistently isolate three to four distinct populations of lysosomes depending on the lipid 
loading conditions.  We could isolate these fractions and compare them to lysosomes 
isolated from untreated macrophages.  The first population to analyze would be the 
heaviest or normal density lysosomes because these lysosomes have differential activity 
of the v-ATPase between agg-LDL loaded and untreated macrophages (Figure 13).  Thus 
the v-ATPase is already affected, yet the protein to lipid ratio is similar between the 
fractions.  To examine the possibility that there is an error in trafficking of the v-ATPase 
or second ion transporter, the proteome of the lysosomal populations could be analyzed.  
This will allow for the examination for the loss of proteins between the two fractions, 
which has been utilized in other systems for similar purposes (Lee et al., 2006; Sadowski 
et al., 2006).  If a transporter is lost then it would have to be confirmed using 
fluorescence microscopy, since there is the possibility that a transporter could be lost 
during the isolation phase of the sample preparation.  Additionally, fluorescence 
microscopy could be conducted because this technique would allow for the colocalization 
of other lysosomal proteins.  If these experiments were conducted it would allow for 
great insight into foam cell formation and lysosomal function.  Some potential 
transporters to focus on would be a chloride channel or the sodium/potassium transporters 
identified to be affected by cholesterol in other systems (Yeagle et al., 1988).  These 
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transporters should be examined because both transporters have the ability to generate a 
membrane potential.   If there is no error in trafficking, membrane properties could be 
related to an inhibition of the second transporter or there is an increase in the membrane 
permeability of the lysosome for the specific ion(s) transported.  In either case, these 
studies would have great impact on both the atherosclerosis field and the v-ATPase field, 
in defining the mechanism of v-ATPase activation. 
 
Potential role of lysosomal volume in exacerbating foam cell formation 
In the data presented in this dissertation we have shown that there is an inhibition 
of the v-ATPase as membrane cholesterol increases and that this corresponds with an 
increase in lysosomal pH and decrease in lysosomal function.  With this inhibition of 
lysosomal function, there is also an expansion of the lysosomal compartment as a percent 
of the cell volume.  We have shown that the v-ATPase, which is responsible for the 
acidification of the lysosome, does not change in protein level throughout several loading 
conditions (Figure 10), including some which do not result in an increase in the 
lysosomal pH.  This suggests that the expression levels may already be at a maximum 
once the monocytes differentiates to a macrophage.  With the increase in lysosomal 
expansion it is possible that there may be an increase in the volume of the lysosome 
causing a change in the rate of acidification.  This would occur if the v-ATPases present 
were not able to pump enough protons into the lysosome to maintain its acidity.  
Additionally, it is possible there is a trafficking defect of the v-ATPase as the lysosomal 
cholesterol increases.  This in turn could have an effect on the lysosomal acidification by 
inhibiting an increase in the number of the v-ATPases being delivered to the lysosomes. 
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Very few studies have examined the effect of volume on the rate of acidification, 
but utilizing particle extrusion may provide novel insight into the role volume may play 
in lysosomal acidification (Mui et al., 2003).  While we have shown that the v-ATPase 
activity is modulated by membrane cholesterol levels, we have done so using an isolated 
lysosomal system.  This model is useful for examining membrane effects; however, the 
lysosomes should be of similar size, so any volumetric affects would be lost.  It would be 
interesting to utilize particle extrusion to create lysosomes of defined size and utilize the 
acridine orange quenching method to examine the rate and level of acidification of the 
vesicle lumen.  However, cells incubated with both polystyrene and magnetic beads, 
which will have an increase in overall lysosome size, exhibit active lysosomal pH and v-
ATPase activity.  These data argue against volume being a determining factor for 
lysosomal inactivation.  Those studies, however, did not rule out volume as a possible 
exacerbating factor.   
 
Potential role of v-ATPase trafficking in exacerbating foam cell formation 
There is the possibility that trafficking of the v-ATPase may be affected during 
foam cell formation.  Using our isolated lysosomal system in macrophages loaded with 
agg-LDL, we observe a decrease in the levels of the v-ATPase as the density decreases or 
the lipid to protein ratio increases (data not shown).  However, because lysosomes are 
dynamic organelles, there are ill defined loading controls for this type of experiment.  In 
that there are no set lysosomal markers that remain at a consistent concentration during 
the life of the organelle.  Therefore, without the loading controls determining exact levels 
of the v-ATPase cannot be concluded.  Furthermore, the antibodies currently available for 
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detection of the human v-ATPase are not suitable for immunohistochemistry because of 
nonspecific binding.  With the presence of the nonspecific binding, making a definitive 
conclusion regarding trafficking is not possible.  As antibody specificity and the 
advancement of various molecular biology techniques increase, it will be interesting to 
determine if either lysosomal volume or trafficking of the v-ATPase may play a role in 
the exacerbation in the development of the atherosclerotic macrophage foam cell. 
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CHAPTER V 
CONCLUSIONS 
 
The studies presented in this dissertation focus on the lysosomal sequestration of 
lipid particles, as macrophage foam cells develop.  Previously, our lab found that there is 
a brief period during loading via mildly ox-LDL, agg-LDL, or DISP where lysosomal CE 
hydrolysis functions normally.  The active hydrolysis of the lipid particles result in the 
generation of FC and fatty acids; however, with these particles the FC generated 
accumulates within the lysosome.  In the studies presented in this dissertation it was 
determined that after this brief active period, the lysosomal pH increases to a level where 
the lysosomes are no longer active.  Additionally, pharmacological accumulation of FC in 
the lysosome corresponds with an increase in the lysosomal pH to inactive levels.  
Further analysis revealed that a potential mechanism behind this increase in lysosome pH 
is that the FC in the lysosomal membrane is inhibiting the v-ATPase.  These v-ATPases 
are the proton pumps of the lysosome and are responsible for maintaining the acidity of 
the structure.  
 In atherosclerosis, the hallmark of the lesion is the presence of macrophage foam 
cells.  In these cells there is a significant increase in the internal cholesterol levels, which 
when sequestered in the lysosomes, could enhance the lysosome membrane cholesterol 
levels to more closely resemble the concentration in the plasma membrane.  This could 
be important, because the v-ATPases are thought to be activated as they move internally 
from the plasma membrane (Hurtado-Lorenzo et al., 2006) possibly due to a reduction in 
membrane cholesterol (Liscum and Munn, 1999).  Therefore, cholesterol effects on 
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membrane properties may play a role in this activation, which appears to be ultamately 
inhibited in the macrophage foam cell.  Additionally, our studies show that the 
inactivation of the v-ATPase is reversible.  The reversibility of the v-ATPase inhibition 
suggests that therapies which increase the egression of the cholesterol from the lysosome 
could possibly reactivate lysosomes and could potentially lead to the regression of the 
lesion.  Some of these therapies could involve the increased expression of NPC-1 and 
NPC-2 proteins.  These proteins are two of the known sterol transporters in the cell and 
their activation could transport cholesterol out of the lysosomal membrane, thus reducing 
the membrane cholesterol concentration. 
Overall, the data presented in this dissertation are consistent with the hypothesis 
that cholesterol accumulation in lysosomes, particularly FC, contributes to the failure of 
lysosomes to maintain an active pH. The experiments presented in this dissertation also 
highlight the fact that cholesterol can modulate lysosome function through changing the 
activity of the v-ATPase.  Furthermore, accumulation of cholesterol within lysosomes 
can produce an acquired lysosomal insufficiency. Importantly, we show that several 
different types of particles, similar to those implicated in atherosclerosis, can bring about 
this insufficiency. Thus, these data suggest a partial explanation for why the foam cells in 
advanced lesions have a similar lysosomal phenotype despite the presence of multiple 
sources of cholesterol. Lastly, we show here for the first time that the cholesterol 
delivered to lysosomes as a component of modified lipoproteins has the potential to 
inhibit v-ATPase activity in human macrophages.  The long-term nature of the inhibition 
would suggest that once a foam cell’s lysosomes are inhibited they do not regain 
function. Since a macrophage can exist within a lesion for extended periods, the failure of 
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acidification and subsequent trapping of cholesterol within this key organelle for 
macrophage function would suggest this defect can influence the nature and progression 
of the atherosclerotic lesion. 
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